Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Ayala, Antonio ^a   Muñoz, Mario F ^a   Argüelles, Sandro ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; CELL DEATH; FREE RADICALS; GENE EXPRESSION; LIPIDS; MAMMALS; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGY; POLYUNSATURATED FATTY ACIDS;

BIOCHEMICAL CONCEPTS; CARBON-CARBON DOUBLE BONDS; MAMMALIAN MODEL SYSTEM; OMEGA-6 FATTY ACIDS; PATHOLOGICAL PROCESS; POLYUNSATURATED FATTY ACIDS (PUFAS); PROTECTIVE FUNCTION; SIGNALING MECHANISMS;

CELL SIGNALING;

4 HYDROXYNONENAL; CADMIUM; CARBON; CARBON TETRACHLORIDE; CHROMIUM; COPPER; CUMENE HYDROPEROXIDE; FREE RADICAL; IRON; LIPID; MALONALDEHYDE; MANGANESE; NICKEL; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE; VANADIUM; 4-HYDROXY-2-NONENAL; ALDEHYDE;

APOPTOSIS; AUTOPHAGY; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL BOND; FENTON REACTION; GENE EXPRESSION; HUMAN; LIPID METABOLISM; LIPID PEROXIDATION; MOLECULAR MECHANICS; NONHUMAN; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL MODEL; METABOLISM;

ALDEHYDES; ANIMALS; HUMANS; LIPID PEROXIDATION; MALONDIALDEHYDE; MODELS, ANIMAL; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84901917562     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/360438     Document Type: Review

References (434)

1. Frühbeck G., Gómez-Ambrosi J., Muruzábal F. J., Burrell M. A., The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. The American Journal of Physiology: Endocrinology and Metabolism 2001 280 6 E827 E847 (Pubitemid 32553225)
2. Frayn K. N., Regulation of fatty acid delivery in vivo. Advances in Experimental Medicine and Biology 1998 441 171 179 (Pubitemid 28428990)
3. Vance E., Vance J. E., Biochemistry: Biochemistry of Lipids, Lipoproteins and Membranes 2002 4th
4. Massey K. A., Nicolaou A., Lipidomics of polyunsaturated-fatty-acid- derived oxygenated metabolites. Biochemical Society Transactions 2011 39 5 1240 1246 2-s2.0-80053370162 10.1042/BST0391240
5. Massey K. A., Nicolaou A., Lipidomics of oxidized polyunsaturated fatty acids. Free Radical Biology and Medicine 2013 59 45 55
6. Jornayvaz F. R., Shulman G. I., Diacylglycerol activation of protein kinase C ε and hepatic insulin resistance. Cell Metabolism 2012 15 5 574 584 2-s2.0-84860497397 10.1016/j.cmet.2012.03.005
7. Giorgi C., Agnoletto C., Baldini C., Bononi A., Bonora M., Marchi S., Missiroli S., Patergnani S., Poletti F., Rimessi A., Zavan B., Pinton P., Redox control of protein kinase C: cell-and disease-specific aspects. Antioxidants and Redox Signaling 2010 13 7 1051 1085 2-s2.0-77955916237 10.1089/ars.2009.2825
8. Yang C., Kazanietz M. G., Chimaerins: GAPs that bridge diacylglycerol signalling and the small G-protein Rac. Biochemical Journal 2007 403 1 1 12 (Pubitemid 46569861)
9. Baumann J., Sevinsky C., Conklin D. S., Lipid biology of breast cancer. Biochimica et Biophysica Acta 2013 1831 10 1509 1517
10. Fisher S. K., Novak J. E., Agranoff B. W., Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. Journal of Neurochemistry 2002 82 4 736 754 2-s2.0-0036677944 10.1046/j.1471-4159.2002.01041.x
11. Conway S. J., Miller G. J., Biology-enabling inositol phosphates, phosphatidylinositol phosphates and derivatives. Natural Product Reports 2007 24 4 687 707 2-s2.0-34547102761 10.1039/b407701f (Pubitemid 47106911)
12. Takuwa Y., Okamoto Y., Yoshioka K., Takuwa N., Sphingosine-1-phosphate signaling in physiology and diseases. BioFactors 2012 38 5 329 337
13. Mattson M. P., Membrane Lipid Signaling in Aging and Age-Related Disease 2003 Elsevier
14. Hannun Y. A., Obeid L. M., Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Reviews Molecular Cell Biology 2008 9 2 139 150 (Pubitemid 351158911)
15. Aoki T., Narumiya S., Prostaglandins and chronic inflammation. Trends in Pharmacological Sciences 2012 33 6 304 311
16. Tang E. H. C., Libby P., Vanhoutte P. M., Xu A., Anti-inflammation therapy by activation of prostaglandin EP4 receptor in cardiovascular and other inflammatory diseases. Journal of Cardiovascular Pharmacology 2012 59 2 116 123 2-s2.0-84857053651 10.1097/FJC.0b013e3182244a12
17. 2 Journal of Immunology 2012 188 1 21 28
18. Kay J. G., Grinstein S., Phosphatidylserine-mediated cellular signaling. Advances in Experimental Medicine and Biology 2013 991 177 193
19. Pluchino N., Russo M., Santoro A. N., Litta P., Cela V., Genazzani A. R., Steroid hormones and BDNF. Neuroscience 2013 239 271 279
20. Moldovan L., Moldovan N. I., Oxygen free radicals and redox biology of organelles. Histochemistry and Cell Biology 2004 122 4 395 412 2-s2.0-8644255769 10.1007/s00418-004-0676-y (Pubitemid 39506596)
21. Lane N., Oxygen: The Molecule that Made the World 2002 Oxford University Press
22. Halliwell B., Gutteridge J. M. C., Oxygen toxicity, oxygen radicals, transition metals and disease. Biochemical Journal 1984 219 1 1 14 2-s2.0-0021351203 (Pubitemid 14171443)
23. Venero J. L., Revuelta M., Atiki L., Santiago M., Tomás-Camardiel M. C., Cano J., Machado A., Evidence for dopamine-derived hydroxyl radical formation in the nigrostriatal system in response to axotomy. Free Radical Biology and Medicine 2003 34 1 111 123 2-s2.0-0037220471 10.1016/S0891-5849(02) 01191-7 (Pubitemid 36043892)
24. Castellani R. J., Honda K., Zhu X., Cash A. D., Nunomura A., Perry G., Smith M. A., Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Research Reviews 2004 3 3 319 326 2-s2.0-3042838351 10.1016/j.arr.2004.01.002 (Pubitemid 38849409)
25. Lipinski B., Pretorius E., Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron. Hematology 2012 17 4 241 247
26. Dizdaroglu M., Jaruga P., Mechanisms of free radical-induced damage to DNA. Free Radical Research 2012 46 4 382 419 2-s2.0-84858133452 10.3109/10715762.2011.653969
27. Kanno T., Nakamura K., Ikai H., Kikuchi K., Sasaki K., Niwano Y., Literature review of the role of hydroxyl radicals in chemically-induced mutagenicity and carcinogenicity for the risk assessment of a disinfection system utilizing photolysis of hydrogen peroxide. Journal of Clinical Biochemistry and Nutrition 2012 51 1 9 14
28. Bielski B. H. J., Arudi R. L., Sutherland M. W., A study of the reactivity of HO2/O2- with unsaturated fatty acids. Journal of Biological Chemistry 1983 258 8 4759 4761 2-s2.0-0020646527
29. Schneider C., Boeglin W. E., Yin H., Porter N. A., Brash A. R., Intermolecular peroxyl radical reactions during autoxidation of hydroxy and hydroperoxy arachidonic acids generate a novel series of epoxidized products. Chemical Research in Toxicology 2008 21 4 895 903 2-s2.0-43149115625 10.1021/tx700357u (Pubitemid 351644568)
30. Browne R. W., Armstrong D., HPLC analysis of lipid-derived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma. Clinical Chemistry 2000 46 6, part 1 829 836 2-s2.0-0034044702 (Pubitemid 30397447)
31. Yin H., Xu L., Porter N. A., Free radical lipid peroxidation: mechanisms and analysis. Chemical Reviews 2011 111 10 5944 5972 2-s2.0-80054089650 10.1021/cr200084z
32. Volinsky R., Kinnunen P. K. J., Oxidized phosphatidylcholines in membrane-level cellular signaling: from biophysics to physiology and molecular pathology. FEBS Journal 2013 280 12 2806 2816
33. Kinnunen P. K. J., Kaarniranta K., Mahalka A. K., Protein-oxidized phospholipid interactions in cellular signaling for cell death: from biophysics to clinical correlations. Biochimica et Biophysica Acta 2012 1818 10 2446 2455
34. Reis A., Spickett C. M., Chemistry of phospholipid oxidation. Biochimica et Biophysica Acta 2012 1818 10 2374 2387
35. Fruhwirth G. O., Loidl A., Hermetter A., Oxidized phospholipids: from molecular properties to disease. Biochimica et Biophysica Acta: Molecular Basis of Disease 2007 1772 7 718 736 2-s2.0-34249991689 10.1016/j.bbadis.2007.04.009 (Pubitemid 46891216)
36. Girotti A. W., Lipid hydroperoxide generation, turnover, and effector action in biological systems. Journal of Lipid Research 1998 39 8 1529 1542 2-s2.0-0031821531 (Pubitemid 28377917)
37. Kanner J., German J. B., Kinsella J. E., Initiation of lipid peroxidation in biological systems. Critical Reviews in Food Science and Nutrition 1987 25 4 317 364 2-s2.0-0023064892
38. Esterbauer H., Cheeseman K. H., Dianzani M. U., Separation and characterization of the aldehydic products of lipid peroxidation stimulated by ADP-Fe2+ in rat liver microsomes. Biochemical Journal 1982 208 1 129 140 2-s2.0-0020365443 (Pubitemid 13215400)
39. Poli G., Dianzani M. U., Cheeseman K. H., Slater T. F., Lang J., Esterbauer H., Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochemical Journal 1985 227 2 629 638 2-s2.0-0021842533 (Pubitemid 15067738)
40. Benedetti A., Comporti M., Esterbauer H., Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochimica et Biophysica Acta 1980 620 2 281 296 2-s2.0-0019193338 (Pubitemid 11216247)
41. Cadenas E., Müller A., Brigelius R., Esterbauer H., Sies H., Effects of 4-hydroxynonenal on isolated hepatocytes. Studies on chemiluminescence response, alkane production and glutathione status. Biochemical Journal 1983 214 2 479 487 2-s2.0-0020510128 (Pubitemid 13035530)
42. Esterbauer H., Lang J., Zadravec S., Slater T. F., Detection of malonaldehyde by high-performance liquid chromatography. Methods in Enzymology 1984 105 319 328 2-s2.0-0021288842 (Pubitemid 14165393)
43. Winkler P., Lindner W., Esterbauer H., Schauenstein E., Schaur R. J., Khoschsorur G. A., Detection of 4-hydroxynonenal as a product of lipid peroxidation in native Ehrlich ascites tumor cells. Biochimica et Biophysica Acta: Lipids and Lipid Metabolism 1984 796 3 232 237 2-s2.0-0021704943 10.1016/0005-2760(84)90122-X (Pubitemid 15158769)
44. Esterbauer H., Benedetti A., Lang J., Fulceri R., Fauler G., Comporti M., Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation. Biochimica et Biophysica Acta: Lipids and Lipid Metabolism 1986 876 1 154 166 2-s2.0-0022548096 (Pubitemid 16011009)
45. Hurst J. S., Slater T. F., Lang J., Effects of the lipid peroxidation product 4-hydroxynonenal on the aggregation of human platelets. Chemico-Biological Interactions 1987 61 2 109 124 2-s2.0-0023150756 (Pubitemid 17056445)
46. Cheeseman K. H., Beavis A., Esterbauer H., Hydroxyl-radical-induced iron-catalysed degradation of 2-deoxyribose. Quantitative determination of malondialdehyde. Biochemical Journal 1988 252 3 649 653 2-s2.0-0023916221
47. Esterbauer H., Zolliner H., Methods for determination of aldehydic lipid peroxidation products. Free Radical Biology and Medicine 1989 7 2 197 203 2-s2.0-0024468045 (Pubitemid 19220721)
48. Esterbauer H., Cheeseman K. H., Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods in Enzymology 1990 186 407 421 2-s2.0-0025127633 10.1016/0076-6879(90)86134-H (Pubitemid 20279982)
49. Esterbauer H., Schaur R. J., Zollner H., Chemistry and Biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991 11 1 81 128 2-s2.0-0025814980 10.1016/0891-5849(91)90192-6 (Pubitemid 121003917)
50. Esterbauer H., Eckl P., Ortner A., Possible mutagens derived from lipids and lipid precursors. Mutation Research 1990 238 3 223 233 2-s2.0-0025305055
51. Pryor W. A., On the detection of lipid hydroperoxides in biological samples. Free Radical Biology and Medicine 1989 7 2 177 178 2-s2.0-0024458152 (Pubitemid 19220716)
52. Sinnhuber R. O., Yu T. C., Yu T. C., Characterization of the red pigment formed in the 2-thiobarbituric acid determination of oxidative rancidity. Journal of Food Science 1958 23 6 626 634
53. Giera M., Lingeman H., Niessen W. M. A., Recent advancements in the LC- and GC-based analysis of malondialdehyde (MDA): a brief overview. Chromatographia 2012 75 9-10 433 440 2-s2.0-84859364419 10.1007/s10337-012-2237- 1
54. Schauenstein E., Autoxidation of polyunsaturated esters in water: chemical structure and biological activity of the products. Journal of Lipid Research 1967 8 5 417 428 2-s2.0-0014127225
55. Brambilla G., Sciabà L., Faggin P., Maura A., Marinari U. M., Ferro M., Esterbauer H., Cytotoxicity, DNA fragmentation and sister-chromatid exchange in Chinese hamster ovary cells exposed to the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Mutation Research 1986 171 2-3 169 176 2-s2.0-0022537754 (Pubitemid 16051639)
56. Schaur R. J., Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Molecular Aspects of Medicine 2003 24 4-5 149 159 2-s2.0-0043172509 10.1016/S0098-2997(03)00009-8 (Pubitemid 36945015)
57. Zarkovic N., 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Molecular Aspects of Medicine 2003 24 4-5 281 291 2-s2.0-0043172469 10.1016/S0098-2997(03)00023-2 (Pubitemid 36945028)
58. Niki E., Biomarkers of lipid peroxidation in clinical material. Biochimica et Biophysica Acta 2014 1840 2 809 817
59. Argüelles S., García S., Maldonado M., Machado A., Ayala A., Do the serum oxidative stress biomarkers provide a reasonable index of the general oxidative stress status? Biochimica et Biophysica Acta: General Subjects 2004 1674 3 251 259 2-s2.0-7944227479 10.1016/j.bbagen.2004.06.023 (Pubitemid 39469284)
60. Argüelles S., Gómez A., Machado A., Ayala A., A preliminary analysis of within-subject variation in human serum oxidative stress parameters as a function of time. Rejuvenation Research 2007 10 4 621 636 2-s2.0-37549041636 10.1089/rej.2006.0528
61. Brigelius-Flohé R., Maiorino M., Glutathione peroxidases. Biochimica et Biophysica Acta 2013 1830 5 3289 3303
62. Steinbrenner H., Sies H., Protection against reactive oxygen species by selenoproteins. Biochimica et Biophysica Acta: General Subjects 2009 1790 11 1478 1485 2-s2.0-72649102374 10.1016/j.bbagen.2009.02.014
63. Valko M., Morris H., Cronin M. T. D., Metals, toxicity and oxidative stress. Current Medicinal Chemistry 2005 12 10 1161 1208 2-s2.0-18544371009 10.2174/0929867053764635 (Pubitemid 40655271)
64. Szabó C., Ischiropoulos H., Radi R., Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nature Reviews Drug Discovery 2007 6 8 662 680 (Pubitemid 47207751)
65. Winterbourn C. C., Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 2002 181-182 223 227 2-s2.0-0037184780 10.1016/S0300-483X(02)00286-X (Pubitemid 36015703)
66. Malle E., Marsche G., Arnhold J., Davies M. J., Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid. Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids 2006 1761 4 392 415 2-s2.0-33646826643 10.1016/j.bbalip.2006.03.024 (Pubitemid 43776460)
67. Miyamoto S., Ronsein G. E., Prado F. M., Uemi M., Corrêa T. C., Toma I. N., Bertolucci A., Oliveira M. C. B., Motta F. D., Medeiros M. H. G., Mascio P. D., Biological hydroperoxides and singlet molecular oxygen generation. IUBMB Life 2007 59 4-5 322 331 2-s2.0-34248586577 10.1080/15216540701242508 (Pubitemid 46763765)
68. Miyamoto S., Martinez G. R., Rettori D., Augusto O., Medeiros M. H. G., Di Mascio P., Linoleic acid hydroperoxide reacts with hypochlorous acid, generating peroxyl radical intermediates and singlet molecular oxygen. Proceedings of the National Academy of Sciences of the United States of America 2006 103 2 293 298 2-s2.0-31044456412 10.1073/pnas.0508170103 (Pubitemid 43122394)
69. Gracanin M., Hawkins C. L., Pattison D. I., Davies M. J., Singlet-oxygen-mediated amino acid and protein oxidation: formation of tryptophan peroxides and decomposition products. Free Radical Biology and Medicine 2009 47 1 92 102 2-s2.0-67349228432 10.1016/j.freeradbiomed.2009.04.015
70. Davies M. J., Singlet oxygen-mediated damage to proteins and its consequences. Biochemical and Biophysical Research Communications 2003 305 3 761 770 (Pubitemid 36579294)
71. Domingues R. M., Domingues P., Melo T., Pérez-Sala D., Reis A., Spickett C. M., Lipoxidation adducts with peptides and proteins: deleterious modifications or signaling mechanisms? Journal of Proteomics 2013 92 110 131
72. Negre-Salvayre A., Coatrieux C., Ingueneau C., Salvayre R., Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. British Journal of Pharmacology 2008 153 1 6 20 2-s2.0-37849013375 10.1038/sj.bjp.0707395
73. Wang X., Lei X. G., Wang J., Malondialdehyde regulates glucose-stimulated insulin secretion in murine islets via TCF7L2-dependent Wnt signaling pathway. Molecular and Cellular Endocrinology 2014 382 1 8 16
74. García-Ruiz I., de la Torre P., Díaz T., Esteban E., Fernández I., Muñoz-Yagüe T., Solís-Herruzo J. A., Sp1 and Sp3 transcription factors mediate malondialdehyde-induced collagen alpha 1(I) gene expression in cultured hepatic stellate cells. The Journal of Biological Chemistry 2002 277 34 30551 30558 (Pubitemid 34970748)
75. Li L., Davie J. R., The role of Sp1 and Sp3 in normal and cancer cell biology. Annals of Anatomy: Anatomischer Anzeiger 2010 192 5 275 283
76. Zarkovic N., Cipak A., Jaganjac M., Borovic S., Zarkovic K., Pathophysiological relevance of aldehydic protein modifications. Journal of Proteomics 2013 92 239 247
77. Blair I. A., DNA adducts with lipid peroxidation products. Journal of Biological Chemistry 2008 283 23 15545 15549 2-s2.0-47049109950 10.1074/jbc.R700051200
78. Łuczaj W., Skrzydlewska E., DNA damage caused by lipid peroxidation products. Cellular and Molecular Biology Letters 2003 8 2 391 413 (Pubitemid 36834659)
79. Garcia S. C., Grotto D., Bulcão R. P., Moro A. M., Roehrs M., Valentini J., de Freitas F. A., Paniz C., Bubols G. B., Charão M. F., Evaluation of lipid damage related to pathological and physiological conditions. Drug and Chemical Toxicology 2013 36 3 306 312
80. Li G., Chen Y., Hu H., Liu L., Hu X., Wang J., Shi W., Yin D., Association between age-related decline of kidney function and plasma malondialdehyde. Rejuvenation Research 2012 15 3 257 264
81. Sanyal J., Bandyopadhyay S. K., Banerjee T. K., Mukherjee S. C., Chakraborty D. P., Ray B. C., Rao V. R., Plasma levels of lipid peroxides in patients with Parkinson's disease. European Review for Medical and Pharmacological Sciences 2009 13 2 129 132 2-s2.0-65649105438
82. Shanmugam N., Figarola J. L., Li Y., Swiderski P. M., Rahbar S., Natarajan R., Proinflammatory effects of advanced lipoxidation end products in monocytes. Diabetes 2008 57 4 879 888 2-s2.0-42449119729 10.2337/db07-1204
83. Baskol G., Demir H., Baskol M., Kilic E., Ates F., Karakukcu C., Ustdal M., Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochemistry and Function 2006 24 4 307 311 2-s2.0-33745995174 10.1002/cbf.1257 (Pubitemid 44065233)
84. Merendino R. A., Salvo F., Saija A., Di Pasquale G., Tomaino A., Minciullo P. L., Fraccica G., Gangemi S., Malondialdehyde in benign prostate hypertrophy: a useful marker? Mediators of Inflammation 2003 12 2 127 128 2-s2.0-0037789398 10.1080/0962935031000097745 (Pubitemid 36783253)
85. Paggiaro P. L., Bartoli M. L., Novelli F., Costa F., Malagrin L., Melosini L., Bacci E., Cianchetti S., Dente F. L., Di Franco A., Vagaggini B., Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators of Inflammation 2011 2011 7 2-s2.0-80052665199 10.1155/2011/891752 891752
86. Hecker M., Ullrich V., On the mechanism of prostacyclin and thromboxane A2 biosynthesis. Journal of Biological Chemistry 1989 264 1 141 150 2-s2.0-0024494718
87. Sharma R. A., Gescher A., Plastaras J. P., Leuratti C., Singh R., Gallacher-Horley B., Offord E., Marnett L. J., Steward W. P., Plummer S. M., Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis 2001 22 9 1557 1560 2-s2.0-0034801821 (Pubitemid 32898715)
88. Tsikas D., Suchy M. T., Niemann J., Tossios P., Schneider Y., Rothmann S., Gutzki F. M., Frölich J. C., Stichtenoth D. O., Glutathione promotes prostaglandin H synthase (cyclooxygenase)-dependent formation of malondialdehyde and 15(S)-8-iso-prostaglandin F2 α FEBS Letters 2012 586 20 3723 3730
89. Griesser M., Boeglin W. E., Suzuki T., Schneider C., Convergence of the 5-LOX and COX-2 pathways: heme-catalyzed cleavage of the 5S-HETE-derived di-endoperoxide into aldehyde fragments. Journal of Lipid Research 2009 50 12 2455 2462 2-s2.0-70849134064 10.1194/jlr.M900181-JLR200
90. Kadiiska M. B., Gladen B. C., Baird D. D., Graham L. B., Parker C. E., Ames B. N., Basu S., FitzGerald G. A., Lawson J. A., Marnett L. J., Morrow J. D., Murray D. M., Plastaras J., Roberts L. J. II, Rokach J., Shigenaga M. K., Sun J., Walter P. B., Tomer K. B., Barrett J. C., Mason R. P., Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radical Biology and Medicine 2005 38 6 711 718 2-s2.0-13844255036 10.1016/j.freeradbiomed.2004.10.024 (Pubitemid 40249741)
91. Ricciotti E., FitzGerald G. A., Prostaglandins and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 5 986 1000
92. Ekambaram P., Lambiv W., Cazzolli R., Ashton A. W., Honn K. V., The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis. Cancer and Metastasis Reviews 2011 30 3-4 397 408 2-s2.0-83855164044 10.1007/s10555-011-9297-9
93. Yang H., Chen C., Cyclooxygenase-2 in synaptic signaling. Current Pharmaceutical Design 2008 14 14 1443 1451 (Pubitemid 351993045)
94. Pryor W. A., Stanley J. P., Blair E., Autoxidation of polyunsaturated fatty acids: II. A suggested mechanism for the formation of TBA reactive materials from prostaglandin like endoperoxides. Lipids 1976 11 5 370 379 2-s2.0-0017070586
95. Milne G. L., Yin H., Morrow J. D., Human biochemistry of the isoprostane pathway. Journal of Biological Chemistry 2008 283 23 15533 15537 2-s2.0-47049114843 10.1074/jbc.R700047200
96. Gao L., Zackert W. E., Hasford J. J., Danekis M. E., Milne G. L., Remmert C., Reese J., Yin H., Tai H.-H., Dey S. K., Porter N. A., Morrow J. D., Formation of prostaglandins E2 and D2 via the isoprostane pathway. A mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase. Journal of Biological Chemistry 2003 278 31 28479 28489 2-s2.0-0042736215 10.1074/jbc.M303984200 (Pubitemid 36935750)
97. Yin H., Gao L., Tai H.-H., Murphey L. J., Porter N. A., Morrow J. D., Urinary prostaglandin F2 α is generated from the isoprostane pathway and not the cyclooxygenase in humans. Journal of Biological Chemistry 2007 282 1 329 336 2-s2.0-33846963508 10.1074/jbc.M608975200 (Pubitemid 47076631)
98. Brooks J. D., Milne G. L., Yin H., Sanchez S. C., Porter N. A., Morrow J. D., Formation of highly reactive cyclopentenone isoprostane compounds (A 3/J3-isoprostanes) in vivo from eicosapentaenoic acid. Journal of Biological Chemistry 2008 283 18 12043 12055 2-s2.0-45549090724 10.1074/jbc.M800122200
99. Roberts L. J. II, Fessel J. P., Davies S. S., The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathology 2005 15 2 143 148 2-s2.0-17444403972 (Pubitemid 40546170)
100. Onyango A. N., Baba N., New hypotheses on the pathways of formation of malondialdehyde and isofurans. Free Radical Biology and Medicine 2010 49 10 1594 1600 2-s2.0-77957754592 10.1016/j.freeradbiomed.2010.08.012
101. Siu G. M., Draper H. H., Metabolism of malonaldehyde in vivo and in vitro. Lipids 1982 17 5 349 355 2-s2.0-0019920815 (Pubitemid 12058259)
102. Marnett L. J., Buck J., Tuttle M. A., Basu A. K., Bull A. W., Distribution and oxidation of malondialdehyde in mice. Prostaglandins 1985 30 2 241 254 2-s2.0-0022354502 (Pubitemid 16245431)
103. Agadjanyan Z. S., Dmitriev L. F., Dugin S. F., A new role of phosphoglucose isomerase. Involvement of the glycolytic enzyme in aldehyde metabolism. Biochemistry 2005 70 11 1251 1255 2-s2.0-29144484253 10.1007/s10541-005-0255-4 (Pubitemid 41802121)
104. Pizzimenti S., Ciamporcero E., Daga M., Pettazzoni P., Arcaro A., Cetrangolo G., Minelli R., Dianzani C., Lepore A., Gentile F., Barrera G., Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Frontiers in Physiology 2013 4, article 242
105. Skoumalová A., Hort J., Blood markers of oxidative stress in Alzheimer's disease. Journal of Cellular and Molecular Medicine 2012 16 10 2291 2300
106. Mangialasche F., Polidori M. C., Monastero R., Ercolani S., Camarda C., Cecchetti R., Mecocci P., Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Research Reviews 2009 8 4 285 305 2-s2.0-69049109744 10.1016/j.arr.2009.04.002
107. Pamplona R., Dalfó E., Ayala V., Bellmunt M. J., Prat J., Ferrer I., Portero-Otín M., Proteins in human brain cortex are modified by oxidation, glycoxidation, and lipoxidation: effects of Alzheimer disease and identification of lipoxidation targets. Journal of Biological Chemistry 2005 280 22 21522 21530 2-s2.0-20444373701 10.1074/jbc.M502255200 (Pubitemid 40805718)
108. Cristalli D. O., Arnal N., Marra F. A., De Alaniz M. J. T., Marra C. A., Peripheral markers in neurodegenerative patients and their first-degree relatives. Journal of the Neurological Sciences 2012 314 1-2 48 56 2-s2.0-84857037658 10.1016/j.jns.2011.11.001
109. Valko M., Leibfritz D., Moncol J., Cronin M. T. D., Mazur M., Telser J., Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry and Cell Biology 2007 39 1 44 84 2-s2.0-33749986298 10.1016/j.biocel.2006.07.001 (Pubitemid 44566469)
110. López N., Tormo C., De Blas I., Llinares I., Alom J., Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. Journal of Alzheimer's Disease 2013 33 3 823 829
111. Torres L. L., Quaglio N. B., De Souza G. T., Garcia R. T., Dati L. M. M., Moreira W. L., De Melo Loureiro A. P., De Souza-Talarico J. N., Smid J., Porto C. S., De Campos Bottino C. M., Nitrini R., De Moraes Barros S. B., Camarini R., Marcourakis T., Peripheral oxidative stress biomarkers in mild cognitive impairment and alzheimer's disease. Journal of Alzheimer's Disease 2011 26 1 59 68 2-s2.0-80052844164 10.3233/JAD-2011-110284
112. Polidori M. C., Mecocci P., Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. Journal of Alzheimer's Disease 2002 4 6 517 522 2-s2.0-0036970014 (Pubitemid 36142841)
113. Padurariu M., Ciobica A., Hritcu L., Stoica B., Bild W., Stefanescu C., Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neuroscience Letters 2010 469 1 6 10 2-s2.0-72649096229 10.1016/j.neulet.2009.11.033
114. Sanders L. H., Timothy Greenamyre J., Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radical Biology and Medicine 2013 62 111 120
115. Mythri R. B., Venkateshappa C., Harish G., Mahadevan A., Muthane U. B., Yasha T. C., Srinivas Bharath M. M., Shankar S. K., Evaluation of Markers of oxidative stress, antioxidant function and astrocytic proliferation in the striatum and frontal cortex of Parkinson's disease brains. Neurochemical Research 2011 36 8 1452 1463 2-s2.0-79961207643 10.1007/s11064-011-0471-9
116. Navarro A., Boveris A., Bández M. J., Sánchez-Pino M. J., Gómez C., Muntané G., Ferrer I., Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies. Free Radical Biology and Medicine 2009 46 12 1574 1580
117. Kilinç A., Yalçin A. S., Yalçin D., Taga Y., Emerk K., Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease. Neuroscience Letters 1988 87 3 307 310
118. Baillet A., Chanteperdrix V., Trocmé C., Casez P., Garrel C., Besson G., The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease. Neurochemical Research 2010 35 10 1530 1537 2-s2.0-77957562993 10.1007/s11064-010-0212-5
119. Chen C. M., Liu J. L., Wu Y. R., Chen Y. C., Cheng H. S., Cheng M. L., Chiu D. T. Y., Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease. Neurobiology of Disease 2009 33 3 429 435
120. Kalra J., Rajput A. H., Mantha S. V., Chaudhary A. K., Prasad K., Oxygen free radical producing activity of polymorphonuclear leukocytes in patients with Parkinson's disease. Molecular and Cellular Biochemistry 1992 112 2 181 186 2-s2.0-0026728880
121. Younes-Mhenni S., Frih-Ayed M., Kerkeni A., Bost M., Chazot G., Peripheral blood markers of oxidative stress in Parkinson's disease. European Neurology 2007 58 2 78 83 2-s2.0-34547788327 10.1159/000103641 (Pubitemid 47237650)
122. Niedernhofer L. J., Daniels J. S., Rouzer C. A., Greene R. E., Marnett L. J., Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. Journal of Biological Chemistry 2003 278 33 31426 31433 2-s2.0-0041731614 10.1074/jbc.M212549200 (Pubitemid 36994664)
123. Del Rio D., Stewart A. J., Pellegrini N., A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutrition, Metabolism and Cardiovascular Diseases 2005 15 4 316 328 2-s2.0-23944478990 10.1016/j.numecd.2005.05.003 (Pubitemid 41190990)
124. VanderVeen L. A., Hashim M. F., Shyr Y., Marnett L. J., Induction of frameshift and base pair substitution mutations by the major DNA adduct of the endogenous carcinogen malondialdehyde. Proceedings of the National Academy of Sciences of the United States of America 2003 100 24 14247 14252 2-s2.0-0344630253 10.1073/pnas.2332176100 (Pubitemid 37499222)
125. Peluso M. E. M., Munnia A., Bollati V., Srivatanakul P., Jedpiyawongse A., Sangrajrang S., Ceppi M., Giese R. W., Boffetta P., Baccarelli A. A., Aberrant methylation of hypermethylated-in-cancer-1 and exocyclic DNA adducts in tobacco smokers. Toxicological Sciences 2014 137 1 47 54
126. Cai F., Dupertuis Y. M., Pichard C., Role of polyunsaturated fatty acids and lipid peroxidation on colorectal cancer risk and treatments. Current Opinion in Clinical Nutrition and Metabolic Care 2012 15 2 99 106 2-s2.0-84857055180 10.1097/MCO.0b013e32834feab4
127. Nair U., Bartsch H., Nair J., Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans. Free Radical Biology and Medicine 2007 43 8 1109 1120 2-s2.0-34548508693 10.1016/j.freeradbiomed.2007.07.012 (Pubitemid 47374441)
128. Bartsch H., Nair J., Accumulation of lipid peroxidation-derived DNA lesions: potential lead markers for chemoprevention of inflammation-driven malignancies. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis 2005 591 1-2 34 44 2-s2.0-27844525474 10.1016/j.mrfmmm.2005.04.013 (Pubitemid 41654838)
129. Wang M., Dhingra K., Hittelman W. N., Liehr J. G., De Andrade M., Li D., Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiology Biomarkers and Prevention 1996 5 9 705 710 2-s2.0-0029835149 (Pubitemid 26304645)
130. Marnett L. J., Inflammation and cancer: chemical approaches to mechanisms, imaging, and treatment. Journal of Organic Chemistry 2012 77 12 5224 5238
131. Dalleau S., Baradat M., Guéraud F., Huc L., Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death and Differentiation 2013 20 12 1615 1630
132. Barrera G., Oxidative stress and lipid peroxidation products in cancer progression and therapy. ISRN Oncology 2012 2012 21 137289 10.5402/2012/137289
133. Huang H., Kozekov I. D., Kozekova A., Wang H., Lloyd R. S., Rizzo C. J., Stone M. P., DNA cross-link induced by trans-4-hydroxynonenal. Environmental and Molecular Mutagenesis 2010 51 6 625 634 2-s2.0-77955913814 10.1002/em.20599
134. Minko I. G., Kozekov I. D., Harris T. M., Rizzo C. J., Lloyd R. S., Stone M. P., Chemistry and biology of DNA containing 1,N2-deoxyguanosine adducts of the α β -unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chemical Research in Toxicology 2009 22 5 759 778 2-s2.0-67649933847 10.1021/tx9000489
135. Negre-Salvayre A., Auge N., Ayala V., Basaga H., Boada J., Brenke R., Chapple S., Cohen G., Feher J., Grune T., Lengyel G., Mann G. E., Pamplona R., Poli G., Portero-Otin M., Riahi Y., Salvayre R., Sasson S., Serrano J., Shamni O., Siems W., Siow R. C. M., Wiswedel I., Zarkovic K., Zarkovic N., Pathological aspects of lipid peroxidation. Free Radical Research 2010 44 10 1125 1171 2-s2.0-77956574773 10.3109/10715762.2010.498478
136. Chung F.-L., Pan J., Choudhury S., Roy R., Hu W., Tang M.-S., Formation of trans-4-hydroxy-2-nonenal- and other enal-derived cyclic DNA adducts from ω -3 and ω -6 polyunsaturated fatty acids and their roles in DNA repair and human p53 gene mutation. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis 2003 531 1-2 25 36 2-s2.0-0345017021 10.1016/j.mrfmmm.2003.07.001 (Pubitemid 37456722)
137. Lee R., Margaritis M., Channon K. M., Antoniades C., Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Current Medicinal Chemistry 2012 19 16 2504 2520
138. Uchida K., Role of reactive aldehyde in cardiovascular diseases. Free Radical Biology and Medicine 2000 28 12 1685 1696 2-s2.0-0034659147 10.1016/S0891-5849(00)00226-4 (Pubitemid 30628655)
139. Anderson E. J., Katunga L. A., Willis M. S., Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clinical and Experimental Pharmacology and Physiology 2012 39 2 179 193 2-s2.0-84856464242 10.1111/j.1440-1681.2011.05641.x
140. Nwose E. U., Jelinek H. F., Richards R. S., Kerr R. G., Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications. British Journal of Biomedical Science 2007 64 1 35 43 2-s2.0-34250784999 (Pubitemid 46952971)
141. Ho E., Karimi Galougahi K., Liu C. C., Bhindi R., Figtree G. A., Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biology 2013 1 1 483 491
142. Chapple S. J., Cheng X., Mann G. E., Effects of 4-hydroxynonenal on vascular endothelial and smooth muscle cell redox signaling and function in health and disease. Redox Biology 2013 1 1 319 331
143. Mattson M. P., Roles of the lipid peroxidation product 4-hydroxynonenal in obesity, the metabolic syndrome, and associated vascular and neurodegenerative disorders. Experimental Gerontology 2009 44 10 625 633 2-s2.0-70349236876 10.1016/j.exger.2009.07.003
144. Leonarduzzi G., Chiarpotto E., Biasi F., Poli G., 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Molecular Nutrition and Food Research 2005 49 11 1044 1049 2-s2.0-28444442268 10.1002/mnfr.200500090 (Pubitemid 41735564)
145. Slatter D. A., Bolton C. H., Bailey A. J., The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000 43 5 550 557 2-s2.0-0034032816 10.1007/s001250051342 (Pubitemid 30322071)
146. Bhutia Y., Ghosh A., Sherpa M. L., Pal R., Mohanta P. K., Serum malondialdehyde level: surrogate stress marker in the Sikkimese diabetics. Journal of Natural Science, Biology and Medicine 2011 2 1 107 112
147. Mahreen R., Mohsin M., Nasreen Z., Siraj M., Ishaq M., Significantly increased levels of serum malonaldehyde in type 2 diabetics with myocardial infarction. International Journal of Diabetes in Developing Countries 2010 30 1 49 51 2-s2.0-77949628274 10.4103/0973-3930.60006
148. Tiwari B. K., Pandey K. B., Abidi A. B., Rizvi S. I., Markers of oxidative stress during diabetes mellitus. Journal of Biomarkers 2013 2013 8 378790 10.1155/2013/378790
149. Nakhjavani M., Esteghamati A., Nowroozi S., Asgarani F., Rashidi A., Khalilzadeh O., Type 2 diabetes mellitus duration: an independent predictor of serum malondialdehyde levels. Singapore Medical Journal 2010 51 7 582 585 2-s2.0-77956193314
150. Wang C. H., Chang R. W., Ko Y. H., Tsai P. R., Wang S. S., Chen Y. S., Ko W. J., Chang C. Y., Young T. H., Chang K. C., Prevention of arterial stiffening by using low-dose atorvastatin in diabetes is associated with decreased malondialdehyde. PloS ONE 2014 9 3 e90471
151. Jaganjac M., Tirosh O., Cohen G., Sasson S., Zarkovic N., Reactive aldehydes-second messengers of free radicals in diabetes mellitus. Free Radical Research 2013 47 supplement 1 39 48
152. Cohen G., Riahi Y., Shamni O., Guichardant M., Chatgilialoglu C., Ferreri C., Kaiser N., Sasson S., Role of lipid peroxidation and PPAR- δ in amplifying glucose-stimulated insulin secretion. Diabetes 2011 60 11 2830 2842 2-s2.0-80755152865 10.2337/db11-0347
153. Pradeep A. R., Agarwal E., Bajaj P., Rao N. S., 4-Hydroxy-2-nonenal, an oxidative stress marker in crevicular fluid and serum in type 2 diabetes with chronic periodontitis. Contemporary Clinical Dentistry 2013 4 3 281 285
154. Toyokuni S., Yamada S., Kashima M., Ihara Y., Yamada Y., Tanaka T., Hiai H., Seino Y., Uchida K., Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxidants and Redox Signaling 2000 2 4 681 685 2-s2.0-0034527741 (Pubitemid 32062319)
155. Cohen G., Riahi Y., Sunda V., Deplano S., Chatgilialoglu C., Ferreri C., Kaiser N., Sasson S., Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes. Free Radical Biology and Medicine 2013 65 978 987
156. Lupachyk S., Shevalye H., Maksimchyk Y., Drel V. R., Obrosova I. G., PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function. Free Radical Biology and Medicine 2011 50 10 1400 1409 2-s2.0-79955479655 10.1016/j.freeradbiomed.2011.01.037
157. Tuma D. J., Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radical Biology and Medicine 2002 32 4 303 308 2-s2.0-0037082350 10.1016/S0891-5849(01)00742-0 (Pubitemid 34159083)
158. Sampey B. P., Korourian S., Ronis M. J., Badger T. M., Petersen D. R., Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcoholism: Clinical and Experimental Research 2003 27 6 1015 1022 2-s2.0-0037971533 (Pubitemid 36759392)
159. Albano E., Role of adaptive immunity in alcoholic liver disease. International Journal of Hepatology 2012 2012 7 893026 10.1155/2012/893026
160. Thiele G. M., Klassen L. W., Tuma D. J., Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption. Methods in Molecular Biology 2008 447 235 257 2-s2.0-43549103813 10.1007/978-1-59745-242-7-17
161. Das S. K., Vasudevan D. M., Alcohol-induced oxidative stress. Life Sciences 2007 81 3 177 187 2-s2.0-34250824010 10.1016/j.lfs.2007.05.005 (Pubitemid 46978376)
162. Niemelä O., Distribution of ethanol-induced protein adducts in vivo: relationship to tissue injury. Free Radical Biology and Medicine 2001 31 12 1533 1538 (Pubitemid 34024975)
163. Mottaran E., Stewart S. F., Rolla R., Vay D., Cipriani V., Moretti M., Vidali M., Sartori M., Rigamonti C., Day C. P., Albano E., Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Radical Biology and Medicine 2002 32 1 38 45 2-s2.0-18244373003 10.1016/S0891-5849(01)00757-2 (Pubitemid 34045135)
164. Willis M. S., Klassen L. W., Tuma D. J., Sorrell M. F., Thiele G. M., Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation. Alcoholism: Clinical and Experimental Research 2002 26 1 94 106 2-s2.0-0036148631 (Pubitemid 34093516)
165. Dou X., Li S., Wang Z., Gu D., Shen C., Yao T., Song Z., Inhibition of NF- κ B activation by 4-hydroxynonenal contributes to liver injury in a mouse model of alcoholic liver disease. The American Journal of Pathology 2012 181 5 1702 1710
166. Smathers R. L., Galligan J. J., Stewart B. J., Petersen D. R., Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chemico-Biological Interactions 2011 192 1-2 107 112 2-s2.0-79958058366 10.1016/j.cbi.2011.02.021
167. Poli G., Biasi F., Leonarduzzi G., 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Molecular Aspects of Medicine 2008 29 1-2 67 71 2-s2.0-40049104518 10.1016/j.mam.2007.09.016
168. Petersen D. R., Doorn J. A., Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radical Biology and Medicine 2004 37 7 937 945 2-s2.0-4444314070 10.1016/j.freeradbiomed.2004.06.012 (Pubitemid 39164576)
169. Galligan J. J., Smathers R. L., Fritz K. S., Epperson L. E., Hunter L. E., Petersen D. R., Protein carbonylation in a murine model for early alcoholic liver disease. Chemical Research in Toxicology 2012 25 5 1012 1021
170. Perluigi M., Coccia R., Butterfield D. A., 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies. Antioxidants & Redox Signaling 2012 17 11 1590 1609
171. Reed T. T., Lipid peroxidation and neurodegenerative disease. Free Radical Biology and Medicine 2011 51 7 1302 1319 2-s2.0-80052261937 10.1016/j.freeradbiomed.2011.06.027
172. Zarkovic K., 4-hydroxynonenal and neurodegenerative diseases. Molecular Aspects of Medicine 2003 24 4-5 293 303 2-s2.0-0043172468 10.1016/S0098-2997(03) 00024-4 (Pubitemid 36945029)
173. Selley M. L., (E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease. Free Radical Biology and Medicine 1998 25 2 169 174 2-s2.0-0032527641 10.1016/S0891-5849(98)00021-5 (Pubitemid 28293150)
174. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., Mizuno Y., Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America 1996 93 7 2696 2701 2-s2.0-0029917194 10.1073/pnas.93.7.2696 (Pubitemid 26114311)
175. Traverso N., Menini S., Maineri E. P., Patriarca S., Odetti P., Cottalasso D., Marinari U. M., Pronzato M. A., Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins. Journals of Gerontology A: Biological Sciences and Medical Sciences 2004 59 9 890 895 2-s2.0-5644255551 (Pubitemid 39372598)
176. Tuma D. J., Kearley M. L., Thiele G. M., Worrall S., Haver A., Klassen L. W., Sorrell M. F., Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation. Chemical Research in Toxicology 2001 14 7 822 832 2-s2.0-0034938943 10.1021/tx000222a (Pubitemid 32661337)
177. Wang G., Li H., Firoze Khan M., Differential oxidative modification of proteins in MRL+/+ and MRL/lpr mice: increased formation of lipid peroxidation-derived aldehyde-protein adducts may contribute to accelerated onset of autoimmune response. Free Radical Research 2012 46 12 1472 1481
178. Duryee M. J., Klassen L. W., Jones B. L., Willis M. S., Tuma D. J., Thiele G. M., Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde. International Immunopharmacology 2008 8 8 1112 1118 2-s2.0-50949129855 10.1016/j.intimp.2008.03.022
179. Wang G., Ansari G. A. S., Khan M. F., Involvement of lipid peroxidation-derived aldehyde-protein adducts in autoimmunity mediated by trichloroethene. Journal of Toxicology and Environmental Health A: Current Issues 2007 70 23 1977 1985 2-s2.0-35648977125 10.1080/15287390701550888 (Pubitemid 350034921)
180. Wållberg M., Bergquist J., Achour A., Breij E., Harris R. A., Malondialdehyde modification of myelin oligodendrocyte glycoprotein leads to increased immunogenicity and encephalitogenicity. European Journal of Immunology 2007 37 7 1986 1995 2-s2.0-34447537998 10.1002/eji.200636912 (Pubitemid 47065134)
181. Weismann D., Binder C. J., The innate immune response to products of phospholipid peroxidation. Biochimica et Biophysica Acta: Biomembranes 2012 1818 10 2465 2475
182. Slatter D. A., Avery N. C., Bailey A. J., Identification of a new cross-link and unique histidine adduct from bovine serum albumin incubated with malondialdehyde. Journal of Biological Chemistry 2004 279 1 61 69 2-s2.0-0347683483 10.1074/jbc.M310608200 (Pubitemid 38044799)
183. Cheng J., Wang F., Yu D.-F., Wu P.-F., Chen J.-G., The cytotoxic mechanism of malondialdehyde and protective effect of carnosine via protein cross-linking/mitochondrial dysfunction/reactive oxygen species/MAPK pathway in neurons. European Journal of Pharmacology 2011 650 1 184 194 2-s2.0-78649752112 10.1016/j.ejphar.2010.09.033
184. Weismann D., Hartvigsen K., Lauer N., Bennett K. L., Scholl H. P. N., Issa P. C., Cano M., Brandstätter H., Tsimikas S., Skerka C., Superti-Furga G., Handa J. T., Zipfel P. F., Witztum J. L., Binder C. J., Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011 478 7367 76 81 2-s2.0-80053904386 10.1038/nature10449
185. Veneskoski M., Turunen S. P., Kummu O., Nissinen A., Rannikko S., Levonen A.-L., Hörkkö S., Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a. Free Radical Biology and Medicine 2011 51 4 834 843 2-s2.0-79960958491 10.1016/j.freeradbiomed.2011.05.029
186. Kharbanda K. K., Shubert K. A., Wyatt T. A., Sorrell M. F., Tuma D. J., Effect of malondialdehyde-acetaldehyde-protein adducts on the protein kinase C-dependent secretion of urokinase-type plasminogen activator in hepatic stellate cells. Biochemical Pharmacology 2002 63 3 553 562 2-s2.0-0036471578 10.1016/S0006-2952(01)00883-8 (Pubitemid 34169735)
187. Marnett L. J., Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002 181-182 219 222 2-s2.0-18144452679 10.1016/S0300-483X(02)00448-1 (Pubitemid 36015702)
188. Marnett L. J., Lipid peroxidation-DNA damage by malondialdehyde. Mutation Research 1999 424 1-2 83 95
189. Fink S. P., Reddy G. R., Marnett L. J., Mutagenicity in Escherichia coli of the major DNA adduct derived from the endogenous mutagen malondialdehyde. Proceedings of the National Academy of Sciences of the United States of America 1997 94 16 8652 8657 2-s2.0-0030744202 10.1073/pnas.94.16.8652 (Pubitemid 27335094)
190. Vöhringer M.-L., Becker T. W., Krieger G., Jacobi H., Witte I., Synergistic DNA damaging effects of malondialdehyde/Cu(II) in PM2 DNA and in human fibroblasts. Toxicology Letters 1998 94 3 159 166 2-s2.0-0344589347 10.1016/S0378-4274(98)00002-2 (Pubitemid 28230995)
191. Ji C., Rouzer C. A., Marnett L. J., Pietenpol J. A., Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde. Carcinogenesis 1998 19 7 1275 1283 2-s2.0-0031878858 10.1093/carcin/19.7.1275 (Pubitemid 28375380)
192. Willis M. S., Klassen L. W., Carlson D. L., Brouse C. F., Thiele G. M., Malondialdehyde-acetaldehyde haptenated protein binds macrophage scavenger receptor(s) and induces lysosomal damage. International Immunopharmacology 2004 4 7 885 899 2-s2.0-2942522656 10.1016/j.intimp.2004.04.004 (Pubitemid 38739094)
193. Otteneder M. B., Knutson C. G., Daniels J. S., Hashim M., Crews B. C., Remmel R. P., Wang H., Rizzo C., Marnett L. J., In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG. Proceedings of the National Academy of Sciences of the United States of America 2006 103 17 6665 6669 2-s2.0-33646237137 10.1073/pnas.0602017103
194. Cline S. D., Lodeiro M. F., Marnett L. J., Cameron C. E., Arnold J. J., Arrest of human mitochondrial RNA polymerase transcription by the biological aldehyde adduct of DNA, M1dG. Nucleic Acids Research 2010 38 21 7546 7557 2-s2.0-78649839856 10.1093/nar/gkq656
195. Sram R. J., Farmer P., Singh R., Garte S., Kalina I., Popov T. A., Binkova B., Ragin C., Taioli E., Effect of vitamin levels on biomarkers of exposure and oxidative damage-the EXPAH study. Mutation Research: Genetic Toxicology and Environmental Mutagenesis 2009 672 2 129 134 2-s2.0-58649124071 10.1016/j.mrgentox.2008.11.005
196. Spickett C. M., The lipid peroxidation product 4-hydroxy-2-nonenal: advances in chemistry and analysis. Redox Biology 2013 1 1 145 152
197. Usatyuk P. V., Natarajan V., Hydroxyalkenals and oxidized phospholipids modulation of endothelial cytoskeleton, focal adhesion and adherens junction proteins in regulating endothelial barrier function. Microvascular Research 2012 83 1 45 55 2-s2.0-82955237301 10.1016/j.mvr.2011.04.012
198. Sharma R., Sharma A., Chaudhary P., Sahu M., Jaiswal S., Awasthi S., Awasthi Y. C., Role of 4-hydroxynonenal in chemopreventive activities of sulforaphane. Free Radical Biology and Medicine 2012 52 11-12 2177 2185
199. Zimniak P., Relationship of electrophilic stress to aging. Free Radical Biology and Medicine 2011 51 6 1087 1105 2-s2.0-80051801444 10.1016/j. freeradbiomed.2011.05.039
200. Fritz K. S., Petersen D. R., Exploring the biology of lipid peroxidation-derived protein carbonylation. Chemical Research in Toxicology 2011 24 9 1411 1419
201. Butterfield D. A., Reed T., Sultana R., Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease. Free Radical Research 2011 45 1 59 72 2-s2.0-78650147789 10.3109/10715762.2010.520014
202. Balogh L. M., Atkins W. M., Interactions of glutathione transferases with 4-hydroxynonenal. Drug Metabolism Reviews 2011 43 2 165 178
203. Klil-Drori A. J., Ariel A., 15-Lipoxygenases in cancer: a double-edged sword? Prostaglandins & Other Lipid Mediators 2013 106 16 22
204. Brash A. R., Boeglin W. E., Chang M. S., Discovery of a second 15S-lipoxygenase in humans. Proceedings of the National Academy of Sciences of the United States of America 1997 94 12 6148 6152 2-s2.0-0031008470 10.1073/pnas.94.12.6148 (Pubitemid 27270652)
205. Ivanov I., Heydeck D., Hofheinz K., Roffeis J., O'Donnell V. B., Kuhn H., Walther M., Molecular enzymology of lipoxygenases. Archives of Biochemistry and Biophysics 2010 503 2 161 174 2-s2.0-77957021373 10.1016/j.abb.2010.08.016
206. Takamura H., Gardner H. W., Oxygenation of (3Z)-alkenal to (2E)-4-hydroxy-2-alkenal in soybean seed (Glycine max L.). Biochimica et Biophysica Acta: Lipids and Lipid Metabolism 1996 1303 2 83 91 2-s2.0-0030603977 10.1016/0005-2760(96)00076-8 (Pubitemid 26325538)
207. Schneider C., Tallman K. A., Porter N. A., Brash A. R., Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. Journal of Biological Chemistry 2001 276 24 20831 20838 2-s2.0-0035877699 10.1074/jbc.M101821200
208. Riahi Y., Cohen G., Shamni O., Sasson S., Signaling and cytotoxic functions of 4-hydroxyalkenals. American Journal of Physiology: Endocrinology and Metabolism 2010 299 6 E879 E886 2-s2.0-78649676178 10.1152/ajpendo.00508. 2010
209. Mahipal S. V. K., Subhashini J., Reddy M. C., Reddy M. M., Anilkumar K., Roy K. R., Reddy G. V., Reddanna P., Effect of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis. Biochemical Pharmacology 2007 74 2 202 214 2-s2.0-34249980917 10.1016/j.bcp.2007.04.005 (Pubitemid 46890813)
210. Kumar K. A., Arunasree K. M., Roy K. R., Reddy N. P., Aparna A., Reddy G. V., Reddanna P., Effects of (15S)-hydroperoxyeicosatetraenoic acid and (15S)-hydroxyeicosatetraenoic acid on the acute-lymphoblastic-leukaemia cell line Jurkat: activation of the Fas-mediated death pathway. Biotechnology and Applied Biochemistry 2009 52 2 121 133 2-s2.0-60549093622 10.1042/BA20070264
211. Eckl P. M., Genotoxicity of HNE. Molecular Aspects of Medicine 2003 24 4-5 161 165 (Pubitemid 36945016)
212. Siems W., Grune T., Intracellular metabolism of 4-hydroxynonenal. Molecular Aspects of Medicine 2003 24 4-5 167 175 (Pubitemid 36945017)
213. Alary J., Guéraud F., Cravedi J.-P., Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Molecular Aspects of Medicine 2003 24 4-5 177 187 2-s2.0-0041669529 10.1016/S0098-2997(03)00012-8 (Pubitemid 36945018)
214. McElhanon K. E., Bose C., Sharma R., Wu L., Awasthi Y. C., Singh S. P., Gsta4 null mouse embryonic fibroblasts exhibit enhanced sensitivity to oxidants: role of 4-hydroxynonenal in oxidant toxicity. Open Journal of Apoptosis 2013 2 1
215. Black W., Chen Y., Matsumoto A., Thompson D. C., Lassen N., Pappa A., Vasiliou V., Molecular mechanisms of ALDH3A1-mediated cellular protection against 4-hydroxy-2-nonenal. Free Radical Biology and Medicine 2012 52 9 1937 1944 2-s2.0-84859505181 10.1016/j.freeradbiomed.2012.02.050
216. Kong D., Kotraiah V., Modulation of aldehyde dehydrogenase activity affects (±)-4-hydroxy-2E-nonenal (HNE) toxicity and HNE-protein adduct levels in PC12 cells. Journal of Molecular Neuroscience 2012 47 3 595 603 2-s2.0-83255189605 10.1007/s12031-011-9688-y
217. Huang Y., Li W., Kong A. N. T., Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal. Cell & Bioscience 2012 2 1, article 40
218. Zhang Y., Sano M., Shinmura K., Tamaki K., Katsumata Y., Matsuhashi T., Morizane S., Ito H., Hishiki T., Endo J., Zhou H., Yuasa S., Kaneda R., Suematsu M., Fukuda K., 4-Hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. Journal of Molecular and Cellular Cardiology 2010 49 4 576 586 2-s2.0-77956101963 10.1016/j.yjmcc.2010.05.011
219. Siow R. C. M., Ishii T., Mann G. E., Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway. Redox Report 2007 12 1-2 11 15 2-s2.0-33846809497 10.1179/135100007X162167 (Pubitemid 46210347)
220. Tanito M., Agbaga M.-P., Anderson R. E., Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radical Biology and Medicine 2007 42 12 1838 1850 2-s2.0-34248591499 10.1016/j.freeradbiomed.2007.03.018 (Pubitemid 46754760)
221. Ishii T., Itoh K., Ruiz E., Leake D. S., Unoki H., Yamamoto M., Mann G. E., Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circulation Research 2004 94 5 609 616 2-s2.0-1642396537 10.1161/01.RES. 0000119171.44657.45 (Pubitemid 38387743)
222. Miller D. M., Singh I. N., Wang J. A., Hall E. D., Administration of the Nrf2-ARE activators sulforaphane and carnosic acid attenuates 4-hydroxy-2-nonenal-induced mitochondrial dysfunction ex vivo. Free Radical Biology and Medicine 2013 57 1 9
223. Gan L., Johnson J. A., Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochimica et Biophysica Acta: Molecular Basis of Disease 2013 10.1016/j.bbadis.2013.12.011
224. Na H. K., Surh Y. J., Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1. Free Radical Biology and Medicine 2014 67 353 365
225. Seo H. A., Lee I. K., The role of Nrf2: adipocyte differentiation, obesity, and insulin resistance. Oxidative Medicine and Cellular Longevity 2013 2013 7 184598 10.1155/2013/184598
226. Deramaudt T. B., Dill C., Bonay M., Regulation of oxidative stress by Nrf2 in the pathophysiology of infectious diseases. Médecine et Maladies Infectieuses 2013 43 3 100 107
227. Grochot-Przeczek A., Dulak J., Jozkowicz A., Haem oxygenase-1: non-canonical roles in physiology and pathology. Clinical Science 2012 122 3 93 103 2-s2.0-84856380036 10.1042/CS20110147
228. Lin M. H., Yen J. H., Weng C. Y., Wang L., Ha C. L., Wu M. J., Lipid peroxidation end product 4-hydroxy-trans-2-nonenal triggers unfolded protein response and heme oxygenase-1 expression in PC12 cells: roles of ROS and MAPK pathways. Toxicology 2014 315 24 37
229. Ishikado A., Nishio Y., Morino K., Ugi S., Kondo H., Makino T., Kashiwagi A., Maegawa H., Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochemical and Biophysical Research Communications 2010 402 1 99 104 2-s2.0-78049269927 10.1016/j.bbrc.2010.09.124
230. Ueda K., Ueyama T., Yoshida K.-I., Kimura H., Ito T., Shimizu Y., Oka M., Tsuruo Y., Ichinose M., Adaptive HNE-Nrf2-HO-1 pathway against oxidative stress is associated with acute gastric mucosal lesions. American Journal of Physiology: Gastrointestinal and Liver Physiology 2008 295 3 G460 G469 2-s2.0-53449093443 10.1152/ajpgi.00204.2007
231. Holmgren A., Lu J., Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochemical and Biophysical Research Communications 2010 396 1 120 124 2-s2.0-77952311188 10.1016/j.bbrc.2010.03.083
232. Chen Z.-H., Saito Y., Yoshida Y., Sekine A., Noguchi N., Niki E., 4-hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. Journal of Biological Chemistry 2005 280 51 41921 41927 2-s2.0-29644437160 10.1074/jbc.M508556200 (Pubitemid 43023161)
233. Lu S. C., Glutathione synthesis. Biochimica et Biophysica Acta 2013 1830 5 3143 3153
234. Franklin C. C., Backos D. S., Mohar I., White C. C., Forman H. J., Kavanagh T. J., Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligase. Molecular Aspects of Medicine 2009 30 1-2 86 98 2-s2.0-65049090510 10.1016/j.mam.2008.08.009
235. Backos D. S., Fritz K. S., Roede J. R., Petersen D. R., Franklin C. C., Posttranslational modification and regulation of glutamate-cysteine ligase by the α β -unsaturated aldehyde 4-hydroxy-2-nonenal. Free Radical Biology and Medicine 2011 50 1 14 26 2-s2.0-78650692177 10.1016/j.freeradbiomed. 2010.10.694
236. Zhang H., Shih A., Rinna A., Forman H. J., Resveratrol and 4-hydroxynonenal act in concert to increase glutamate cysteine ligase expression and glutathione in human bronchial epithelial cells. Archives of Biochemistry and Biophysics 2009 481 1 110 115 2-s2.0-57449083031 10.1016/j.abb.2008.10.020
237. Zhang H., Court N., Forman H. J., Submicromolar concentrations of 4-hydroxynonenal induce glutamate cysteine ligase expression in HBE1 cells. Redox Report 2007 12 1-2 101 106 2-s2.0-33846849624 10.1179/135100007X162266 (Pubitemid 46210366)
238. Iles K. E., Liu R.-M., Mechanisms of Glutamate Cysteine Ligase (GCL) induction by 4-hydroxynonenal. Free Radical Biology and Medicine 2005 38 5 547 556 2-s2.0-15744393896 10.1016/j.freeradbiomed.2004.11.012 (Pubitemid 40416850)
239. Forman H. J., Dickinson D. A., Iles K. E., HNE-signaling pathways leading to its elimination. Molecular Aspects of Medicine 2003 24 4-5 189 194 2-s2.0-0041625928 10.1016/S0098-2997(03)00013-X (Pubitemid 36957831)
240. Braithwaite E. K., Mattie M. D., Freedman J. H., Activation of metallothionein transcription by 4-hydroxynonenal. Journal of Biochemical and Molecular Toxicology 2010 24 5 330 334 2-s2.0-77958577388 10.1002/jbt.20342
241. Reichard J. F., Petersen D. R., Hepatic stellate cells lack AP-1 responsiveness to electrophiles and phorbol 12-myristate-13-acetate. Biochemical and Biophysical Research Communications 2004 322 3 842 853 2-s2.0-4444233380 10.1016/j.bbrc.2004.07.180 (Pubitemid 39164429)
242. Kikuta K., Masamune A., Satoh M., Suzuki N., Shimosegawa T., 4-Hydroxy-2, 3-nonenal activates activator protein-1 and mitogen-activated protein kinases in rat pancreatic stellate cells. World Journal of Gastroenterology 2004 10 16 2344 2351 2-s2.0-4344659607 (Pubitemid 39157757)
243. Camandola S., Poli G., Mattson M. P., The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1- binding activity through caspase activation in neurons. Journal of Neurochemistry 2000 74 1 159 168 2-s2.0-0033985185 10.1046/j.1471-4159.2000.0740159.x (Pubitemid 30012766)
244. Shaulian E., Karin M., AP-1 as a regulator of cell life and death. Nature Cell Biology 2002 4 5 E131 E136 2-s2.0-0036098552 10.1038/ncb0502-e131 (Pubitemid 34521026)
245. Shaulian E., AP-1-the Jun proteins: oncogenes or tumor suppressors in disguise? Cellular Signalling 2010 22 6 894 899 2-s2.0-77949916262 10.1016/j.cellsig.2009.12.008
246. Morgan M. J., Liu Z., Crosstalk of reactive oxygen species and NF- κ B signaling. Cell Research 2011 21 1 103 115
247. Siomek A., NF- κ B signaling pathway and free radical impact. Acta Biochimica Polonica 2012 59 3 323 331
248. Lim J. H., Lee J.-C., Lee Y. H., Choi I. Y., Oh Y.-K., Kim H.-S., Park J.-S., Kim W.-K., Simvastatin prevents oxygen and glucose deprivation/ reoxygenation-induced death of cortical neurons by reducing the production and toxicity of 4-hydroxy-2E-nonenal. Journal of Neurochemistry 2006 97 1 140 150 2-s2.0-33644946838 10.1111/j.1471-4159.2006.03715.x
249. Kaarniranta K., Ryhänen T., Karjalainen H. M., Lammi M. J., Suuronen T., Huhtala A., Kontkanen M., Teräsvirta M., Uusitalo H., Salminen A., Geldanamycin increases 4-hydroxynonenal (HNE)-induced cell death in human retinal pigment epithelial cells. Neuroscience Letters 2005 382 1-2 185 190 2-s2.0-21144434498 10.1016/j.neulet.2005.03.009 (Pubitemid 40725889)
250. Luckey S. W., Taylor M., Sampey B. P., Scheinman R. I., Petersen D. R., 4-Hydroxynonenal decreases interleukin-6 expression and protein production in primary rat Kupffer cells by inhibiting nuclear factor- B activation. Journal of Pharmacology and Experimental Therapeutics 2002 302 1 296 303 2-s2.0-0036088474 10.1124/jpet.102.033522 (Pubitemid 34680451)
251. Minekura H., Kumagai T., Kawamoto Y., Nara F., Uchida K., 4-Hydroxy-2-nonenal is a powerful endogenous inhibitor of endothelial response. Biochemical and Biophysical Research Communications 2001 282 2 557 561 2-s2.0-0034806091 10.1006/bbrc.2001.4586 (Pubitemid 32917907)
252. Ji C., Kozak K. R., Marnett L. J., I B kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. Journal of Biological Chemistry 2001 276 21 18223 18228 2-s2.0-0035947678 10.1074/jbc.M101266200
253. Lee S. J., Kim C. E., Seo K. W., Kim C. D., HNE-induced 5-LO expression is regulated by NF- B/ERK and Sp1/p38 MAPK pathways via EGF receptor in murine macrophages. Cardiovascular Research 2010 88 2 352 359 2-s2.0-77958081965 10.1093/cvr/cvq194
254. Lee S. J., Seo K. W., Yun M. R., Bae S. S., Lee W. S., Hong K. W., Kim C. D., 4-hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF- B signaling pathways. Free Radical Biology and Medicine 2008 45 10 1487 1492 2-s2.0-54349125514 10.1016/j.freeradbiomed.2008.08.022
255. Raza H., John A., Brown E. M., Benedict S., Kambal A., Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in PC12 cells. Toxicology and Applied Pharmacology 2008 226 2 161 168 2-s2.0-37449012959 10.1016/j.taap.2007.09.002
256. Malone P. E., Hernandez M. R., 4-Hydroxynonenal, a product of oxidative stress, leads to an antioxidant response in optic nerve head astrocytes. Experimental Eye Research 2007 84 3 444 454 2-s2.0-33846818874 10.1016/j.exer.2006.10.020 (Pubitemid 46210058)
257. Vaillancourt F., Morquette B., Shi Q., Fahmi H., Lavigne P., Di Battista J. A., Fernandes J. C., Benderdour M., Differential regulation of cyclooxygenase-2 and inducible nitric oxide synthase by 4-hydroxynonenal in human osteoarthritic chondrocytes through ATF-2/CREB-1 transactivation and concomitant inhibition of NF- B signaling cascade. Journal of Cellular Biochemistry 2007 100 5 1217 1231 2-s2.0-33947585316 10.1002/jcb.21110 (Pubitemid 46480404)
258. Amma H., Naruse K., Ishiguro N., Sokabe M., Involvement of reactive oxygen species in cyclic stretch-induced NF- B activation in human fibroblast cells. British Journal of Pharmacology 2005 145 3 364 373 2-s2.0-21244441080 10.1038/sj.bjp.0706182 (Pubitemid 40896081)
259. Donath B., Fischer C., Page S., Prebeck S., Jilg N., Weber M., Da Costa C., Neumeier D., Miethke T., Brand K., Chlamydia pneumoniae activates IKK/I B-mediated signaling, which is inhibited by 4-HNE and following primary exposure. Atherosclerosis 2002 165 1 79 88 2-s2.0-18644373824 10.1016/S0021-9150(02)00198-3 (Pubitemid 35223170)
260. Kim T., Yang Q., Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system. World Journal of Cardiology 2013 5 6 164 174
261. Ahmadian M., Suh J. M., Hah N., Liddle C., Atkins A. R., Downes M., Evans R. M., PPAR γ signaling and metabolism: the good, the bad and the future. Nature Medicine 2013 19 5 557 566
262. Barrera G., Toaldo C., Pizzimenti S., Cerbone A., Pettazzoni P., Dianzani M. U., Ferretti C., The role of PPAR ligands in controlling growth-related gene expression and their interaction with lipoperoxidation products. PPAR Research 2008 2008 15 2-s2.0-47349107464 10.1155/2008/524671 524671 (Pubitemid 352000621)
263. Wang Z., Dou X., Gu D., Shen C., Yao T., Nguyen V., Braunschweig C., Song Z., 4-Hydroxynonenal differentially regulates adiponectin gene expression and secretion via activating PPAR γ and accelerating ubiquitin-proteasome degradation. Molecular and Cellular Endocrinology 2012 349 2 222 231 2-s2.0-81555230837 10.1016/j.mce.2011.10.027
264. Pizzimenti S., Laurora S., Briatore F., Ferretti C., Dianzani M. U., Barrera G., Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. Free Radical Biology and Medicine 2002 32 3 233 245 2-s2.0-0036468883 10.1016/S0891-5849(01)00798-5 (Pubitemid 34119402)
265. Cerbone A., Toaldo C., Laurora S., Briatore F., Pizzimenti S., Dianzani M. U., Ferretti C., Barrera G., 4-hydroxynonenal and PPAR γ ligands affect proliferation, differentiation, and apoptosis in colon cancer cells. Free Radical Biology and Medicine 2007 42 11 1661 1670 2-s2.0-34247383583 10.1016/j.freeradbiomed.2007.02.009 (Pubitemid 46629012)
266. Almeida M., Ambrogini E., Han L., Manolagas S. C., Jilka R. L., Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor- γ expression, and diminished pro-osteogenic Wnt signaling in the skeleton. Journal of Biological Chemistry 2009 284 40 27438 27448 2-s2.0-70350451479 10.1074/jbc.M109.023572
267. Coleman J. D., Prabhu K. S., Thompson J. T., Reddy P. S., Peters J. M., Peterson B. R., Reddy C. C., Vanden Heuvel J. P., The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor- β / δ (PPAR β / δ). Free Radical Biology and Medicine 2007 42 8 1155 1164 2-s2.0-33947241783 10.1016/j.freeradbiomed.2007.01.003 (Pubitemid 46428510)
268. Zheng R., Po I., Mishin V., Black A. T., Heck D. E., Laskin D. L., Sinko P. J., Gerecke D. R., Gordon M. K., Laskin J. D., The generation of 4-hydroxynonenal, an electrophilic lipid peroxidation end product, in rabbit cornea organ cultures treated with UVB light and nitrogen mustard. Toxicology and Applied Pharmacology 2013 272 2 345 355
269. Zheng R., Heck D. E., Mishin V., Black A. T., Shakarjian M. P., Kong A. N. T., Laskin D. L., Laskin J. D., Modulation of keratinocyte expression of antioxidants by 4-hydroxynonenal, a lipid peroxidation end product. Toxicology and Applied Pharmacology 2014 275 2 113 121 10.1016/j.taap.2014.01.001
270. Uchida K., Kumagai T., 4-Hydroxy-2-nonenal as a COX-2 inducer. Molecular Aspects of Medicine 2003 24 4-5 213 218 2-s2.0-0041669519 10.1016/S0098-2997(03) 00016-5 (Pubitemid 36945021)
271. Parola M., Robino G., Marra F., Pinzani M., Bellomo G., Leonarduzzi G., Chiarugi P., Camandola S., Poli G., Waeg G., Gentilini P., Dianzani M. U., HNE interacts directly with JNK isoforms in human hepatic stellate cells. Journal of Clinical Investigation 1998 102 11 1942 1950 2-s2.0-0032422051 (Pubitemid 29001840)
272. Rinna A., Forman H. J., SHP-1 inhibition by 4-hydroxynonenal activates Jun N-terminal kinase and glutamate cysteine ligase. American Journal of Respiratory Cell and Molecular Biology 2008 39 1 97 104 2-s2.0-45849089850 10.1165/rcmb.2007-0371OC (Pubitemid 351883963)
273. Liu R.-M., Borok Z., Forman H. J., 4-Hydroxy-2-nonenal increases γ -glutamylcysteine synthetase gene expression in alveolar epithelial cells. American Journal of Respiratory Cell and Molecular Biology 2001 24 4 499 505 2-s2.0-0035047707 (Pubitemid 32324740)
274. Dickinson D. A., Iles K. E., Watanabe N., Iwamoto T., Zhang H., Krzywanski D. M., Forman H. J., 4-Hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells. Free Radical Biology and Medicine 2002 33 7 974 987 2-s2.0-0036802703 10.1016/S0891-5849(02)00991-7 (Pubitemid 35284035)
275. Marantos C., Mukaro V., Ferrante J., Hii C., Ferrante A., Inhibition of the lipopolysaccharide-induced stimulation of the members of the MAPK family in human monocytes/macrophages by 4-hydroxynonenal, a product of oxidized omega-6 fatty acids. American Journal of Pathology 2008 173 4 1057 1066 2-s2.0-53149101293 10.2353/ajpath.2008.071150
276. Shi Q., Vaillancourt F., Côté V., Fahmi H., Lavigne P., Afif H., Di Battista J. A., Fernandes J. C., Benderdour M., Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal. Arthritis Research and Therapy 2006 8 6, article R159 2-s2.0-70350593586 10.1186/ar2066
277. Usatyuk P. V., Parinandi N. L., Natarajan V., Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins. Journal of Biological Chemistry 2006 281 46 35554 35566 2-s2.0-33845629703 10.1074/jbc.M607305200 (Pubitemid 46036589)
278. 2 in cultured Ra2 microglial cells via MAPK pathways. Neuropathology 2011 31 2 122 128 2-s2.0-79952731286 10.1111/j.1440-1789.2010. 01139.x
279. Verslegers M., Lemmens K., Van Hove I., Moons L., Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system. Progress in Neurobiology 2013 105 60 78
280. Lee S. J., Kim C. E., Yun M. R., Seo K. W., Park H. M., Yun J. W., Shin H. K., Bae S. S., Kim C. D., 4-Hydroxynonenal enhances MMP-9 production in murine macrophages via 5-lipoxygenase-mediated activation of ERK and p38 MAPK. Toxicology and Applied Pharmacology 2010 242 2 191 198 2-s2.0-71049193819 10.1016/j.taap.2009.10.007
281. Seo K. W., Lee S. J., Kim C. E., Yun M. R., Park H. M., Yun J. W., Bae S. S., Kim C. D., Participation of 5-lipoxygenase-derived LTB4 in 4-hydroxynonenal-enhanced MMP-2 production in vascular smooth muscle cells. Atherosclerosis 2010 208 1 56 61 2-s2.0-73449139739 10.1016/j.atherosclerosis. 2009.06.012
282. Morquette B., Shi Q., Lavigne P., Ranger P., Fernandes J. C., Benderdour M., Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation. Arthritis and Rheumatism 2006 54 1 271 281 2-s2.0-31044435908 10.1002/art.21559 (Pubitemid 43122212)
283. Hers I., Vincent E. E., Tavaré J. M., Akt signalling in health and disease. Cell Signaling 2011 23 10 1515 1527
284. Chalhoub N., Baker S. J., PTEN and the PI3-kinase pathway in cancer. Annual Review of Pathology 2009 4 127 150
285. Shearn C. T., Fritz K. S., Reigan P., Petersen D. R., Modification of Akt2 by 4-hydroxynonenal inhibits insulin-dependent Akt signaling in HepG2 cells. Biochemistry 2011 50 19 3984 3996 2-s2.0-79955830382 10.1021/bi200029w
286. Shearn C. T., Smathers R. L., Backos D. S., Reigan P., Orlicky D. J., Petersen D. R., Increased carbonylation of the lipid phosphatase PTEN contributes to Akt2 activation in a murine model of early alcohol-induced steatosis. Free Radical Biology and Medicine 2013 65 680 692
287. Shearn C. T., Reigan P., Petersen D. R., Inhibition of Hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells. Free Radical Biology and Medicine 2012 53 1 1 11
288. Vatsyayan R., Chaudhary P., Sharma A., Sharma R., Rao Lelsani P. C., Awasthi S., Awasthi Y. C., Role of 4-hydroxynonenal in epidermal growth factor receptor-mediated signaling in retinal pigment epithelial cells. Experimental Eye Research 2011 92 2 147 154 2-s2.0-79451476147 10.1016/j.exer.2010.11.010
289. Turban S., Hajduch E., Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance. FEBS Letters 2011 585 2 269 274 2-s2.0-78651376861 10.1016/j.febslet.2010.12.022
290. Maggiora M., Rossi M. A., The exocytosis induced in HL-60 cells by 4-hydroxynonenal, a lipid peroxidation product, is not prevented by reduced glutathione. Cell Biochemistry and Function 2006 24 1 1 6 2-s2.0-31644440260 10.1002/cbf.1260 (Pubitemid 43171002)
291. Maggiora M., Rossi M. A., Experimental researches on the role of phosphoinositide-specific phospholipase C in 4-hydroxynonenal induced exocytosis. Cell Biochemistry and Function 2003 21 2 155 160 2-s2.0-0037911448 10.1002/cbf.1013 (Pubitemid 36597183)
292. Rossi M. A., Di Mauro C., Dianzani M. U., Experimental studies on the mechanism of phospholipase C activation by the lipid peroxidation products 4-hydroxynonenal and 2-nonenal. International Journal of Tissue Reactions 2001 23 2 45 50 2-s2.0-0034935945 (Pubitemid 32618842)
293. Rossi M. A., Di Mauro C., Esterbauer H., Fidale F., Dianzani M. U., Activation of phosphoinositide-specific phospholipase C of rat neutrophils by the chemotactic aldehydes 4-hydroxy-2,3-trans-nonenal and 4-hydroxy-2,3-trans- octenal. Cell Biochemistry and Function 1994 12 4 275 280 2-s2.0-0028005464 10.1002/cbf.290120408 (Pubitemid 24350569)
294. de Oliveira-Junior E. B., Bustamante J., Newburger P. E., Condino-Neto A., The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scandinavian Journal of Immunology 2011 73 5 420 427 2-s2.0-79953031472 10.1111/j.1365-3083.2010.02501.x
295. Harry R. S., Hiatt L. A., Kimmel D. W., Carney C. K., Halfpenny K. C., Cliffel D. E., Wright D. W., Metabolic impact of 4-hydroxynonenal on macrophage-like RAW 264.7 function and activation. Chemical Research in Toxicology 2012 25 8 1643 1651
296. Chiarpotto E., Domenicotti C., Paola D., Vitali A., Nitti M., Pronzato M. A., Biasi F., Cottalasso D., Marinari U. M., Dragonetti A., Cesaro P., Isidoro C., Poli G., Regulation of rat hepatocyte protein kinase C β isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 1999 29 5 1565 1572 2-s2.0-17044441984 10.1002/hep.510290510 (Pubitemid 29211062)
297. Paola D., Domenicotti C., Nitti M., Vitali A., Borghi R., Cottalasso D., Zaccheo D., Odetti P., Strocchi P., Marinari U. M., Tabaton M., Pronzato M. A., Oxidative stress induces increase in intracellular amyloid β -protein production and selective activation of β I and β II PKCs in NT2 cells. Biochemical and Biophysical Research Communications 2000 268 2 642 646 2-s2.0-0034673209 10.1006/bbrc.2000.2164 (Pubitemid 30119675)
298. Marinari U. M., Nitti M., Pronzato M. A., Domenicotti C., Role of PKC-dependent pathways in HNE-induced cell protein transport and secretion. Molecular Aspects of Medicine 2003 24 4-5 205 211 2-s2.0-0043172499 10.1016/S0098-2997(03)00015-3 (Pubitemid 36945020)
299. Nitti M., Domenicotti C., D'Abramo C., Assereto S., Cottalasso D., Melloni E., Poli G., Biasi F., Marinari U. M., Pronzato M. A., Activation of PKC- β isoforms mediates HNE-induced MCP-1 release by macrophages. Biochemical and Biophysical Research Communications 2002 294 3 547 552 2-s2.0-0036297299 10.1016/S0006-291X(02)00512-0 (Pubitemid 34694043)
300. Ramana K. V., Fadl A. A., Tammali R., Reddy A. B. M., Chopra A. K., Srivastava S. K., Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages. Journal of Biological Chemistry 2006 281 44 33019 33029 2-s2.0-33845962827 10.1074/jbc.M603819200 (Pubitemid 46036684)
301. Dodson M., Darley-Usmar V., Zhang J., Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radical Biology and Medicine 2013 63 207 221
302. Hill B. G., Haberzettl P., Ahmed Y., Srivastava S., Bhatnagar A., Unsaturated lipid peroxidation-derived aldehydes activate autophagy in vascular smooth-muscle cells. Biochemical Journal 2008 410 3 525 534 2-s2.0-41149116150 10.1042/BJ20071063 (Pubitemid 351429023)
303. Haberzettl P., Hill B. G., Oxidized lipids activate autophagy in a JNK-dependent manner by stimulating the endoplasmic reticulum stress response. Redox Biology 2013 1 1 56 64
304. Dodson M., Liang Q., Johnson M. S., Redmann M., Fineberg N., Darley-Usmar V. M., Zhang J., Inhibition of glycolysis attenuates 4-hydroxynonenal-dependent autophagy and exacerbates apoptosis in differentiated SH-SY5Y neuroblastoma cells. Autophagy 2013 9 12 1996 2008
305. Krohne T. U., Stratmann N. K., Kopitz J., Holz F. G., Effects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells. Experimental Eye Research 2010 90 3 465 471 2-s2.0-77649188326 10.1016/j.exer.2009.12.011
306. Fyhrquist F., Saijonmaa O., Strandberg T., The roles of senescence and telomere shortening in cardiovascular disease. Nature Reviews Cardiology 2013 10 5 274 283
307. Olive P. L., Endogenous DNA breaks: gammaH2AX and the role of telomeres. Aging 2009 1 2 154 156 2-s2.0-77951977367
308. Günes C., Rudolph K. L., The role of telomeres in stem cells and cancer. Cell 2013 152 3 390 393
309. Argüelles S., Machado A., Ayala A., Adduct formation of 4-hydroxynonenal and malondialdehyde with elongation factor-2 in vitro and in vivo. Free Radical Biology and Medicine 2009 47 3 324 330 2-s2.0-67349218427 10.1016/j.freeradbiomed.2009.05.010
310. Wang C., Maddick M., Miwa S., Jurk D., Czapiewski R., Saretzki G., Langie S. A. S., Godschalk R. W. L., Cameron K., von Zglinicki T., Adult-onset, short-term dietary restriction reduces cell senescence in mice. Aging 2010 2 9 555 566 2-s2.0-79952118049
311. Nelson G., Wordsworth J., Wang C., Jurk D., Lawless C., Martin-Ruiz C., von Zglinicki T., A senescent cell bystander effect: senescence-induced senescence. Aging Cell 2012 11 2 345 349 2-s2.0-84858343297 10.1111/j.1474-9726. 2012.00795.x
312. Voghel G., Thorin-Trescases N., Farhat N., Mamarbachi A. M., Villeneuve L., Fortier A., Perrault L. P., Carrier M., Thorin E., Chronic treatment with N-acetyl-cystein delays cellular senescence in endothelial cells isolated from a subgroup of atherosclerotic patients. Mechanisms of Ageing and Development 2008 129 5 261 270 2-s2.0-41449094458 10.1016/j.mad.2008.01.004
313. Pizzimenti S., Briatore F., Laurora S., Toaldo C., Maggio M., De Grandi M., Meaglia L., Menegatti E., Giglioni B., Dianzani M. U., Barrera G., 4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines. Free Radical Biology and Medicine 2006 40 9 1578 1591 2-s2.0-33646040063 10.1016/j.freeradbiomed.2005.12.024
314. Pizzimenti S., Menegatti E., Berardi D., Toaldo C., Pettazzoni P., Minelli R., Giglioni B., Cerbone A., Dianzani M. U., Ferretti C., Barrera G., 4-Hydroxynonenal, a lipid peroxidation product of dietary polyunsaturated fatty acids, has anticarcinogenic properties in colon carcinoma cell lines through the inhibition of telomerase activity. Journal of Nutritional Biochemistry 2010 21 9 818 826 2-s2.0-77955843950 10.1016/j.jnutbio.2009.06.005
315. Rufini A., Tucci P., Celardo I., Melino G., Senescence and aging: the critical roles of p53. Oncogene 2013 32 43 5129 5143
316. Qian Y., Chen X., Senescence regulation by the p53 protein family. Methods in Molecular Biology 2013 965 37 61
317. Sahin E., DePinho R. A., Axis of ageing: telomeres, p53 and mitochondria. Nature Reviews Molecular Cell Biology 2012 13 6 397 404
318. Liu D., Xu Y., P53, oxidative stress, and aging. Antioxidants and Redox Signaling 2011 15 6 1669 1678 2-s2.0-79961180595 10.1089/ars.2010.3644
319. Hafsi H., Hainaut P., Redox control and interplay between p53 isoforms: roles in the regulation of basal p53 levels, cell fate, and senescence. Antioxidants and Redox Signaling 2011 15 6 1655 1667 2-s2.0-79961199862 10.1089/ars.2010.3771
320. Vigneron A., Vousden K. H., p53, ROS and senescence in the control of aging. Aging 2010 2 8 471 474 2-s2.0-78650152988
321. Verbon E. H., Post J. A., Boonstra J., The influence of reactive oxygen species on cell cycle progression in mammalian cells. Gene 2012 511 1 1 6
322. Chiu J., Dawes I. W., Redox control of cell proliferation. Trends in Cell Biology 2012 22 11 592 601
323. Lim S., Kaldis P., Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development 2013 140 15 3079 3093
324. Barrera G., Pizzimenti S., Laurora S., Moroni E., Giglioni B., Dianzani M. U., 4-hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells. Biochemical and Biophysical Research Communications 2002 295 2 267 275 2-s2.0-0036069845 10.1016/S0006-291X(02)00649-6 (Pubitemid 34785828)
325. Pizzimenti S., Barrera G., Dianzani M. U., Brüsselbach S., Inhibition of D1, D2, and A cyclin expression in HL-60 cells by the lipid peroxydation product 4-hydroxynonenal. Free Radical Biology and Medicine 1999 26 11-12 1578 1586 2-s2.0-0033004490 10.1016/S0891-5849(99)00022-2 (Pubitemid 29302291)
326. Skorokhod O. A., Caione L., Marrocco T., Migliardi G., Barrera V., Arese P., Piacibello W., Schwarzer E., Inhibition of erythropoiesis in malaria anemia: role of hemozoin and hemozoin-generated 4-hydroxynonenal. Blood 2010 116 20 4328 4337 2-s2.0-78549286042 10.1182/blood-2010-03-272781
327. Albright C. D., Klem E., Shah A. A., Gallagher P., Breast cancer cell-targeted oxidative stress: enhancement of cancer cell uptake of conjugated linoleic acid, activation of p53, and inhibition of proliferation. Experimental and Molecular Pathology 2005 79 2 118 125 2-s2.0-24344490190 10.1016/j.yexmp.2005.05.005 (Pubitemid 41262493)
328. Sunjic S. B., Cipak A., Rabuzin F., Wildburger R., Zarkovic N., The influence of 4-hydroxy-2-nonenal on proliferation, differentiation and apoptosis of human osteosarcoma cells. BioFactors 2005 24 1-4 141 148 2-s2.0-28644440011 (Pubitemid 41750537)
329. Muzio G., Trombetta A., Martinasso G., Canuto R. A., Maggiora M., Antisense oligonucleotides against aldehyde dehydrogenase 3 inhibit hepatoma cell proliferation by affecting MAP kinases. Chemico-Biological Interactions 2003 143-144 37 43 2-s2.0-0037324844 10.1016/S0009-2797(02)00170-9 (Pubitemid 36253577)
330. Canuto R. A., Muzio G., Ferro M., Maggiora M., Federa R., Bassi A. M., Lindahl R., Dianzani M. U., Inhibition of class-3 aldehyde dehydrogenase and cell growth by restored lipid peroxidation in hepatoma cell lines. Free Radical Biology and Medicine 1999 26 3-4 333 340 2-s2.0-0032957410 10.1016/S0891- 5849(98)00206-8 (Pubitemid 29013464)
331. Pizzimenti S., Barrera G., Calzavara E., Mirandola L., Toaldo C., Dianzani M. U., Comi P., Chiaramonte R., Down-regulation of Notch1 expression is involved in HL-60 cell growth inhibition induced by 4-hydroxynonenal, a product of lipid peroxidation. Medicinal Chemistry 2008 4 6 551 557 2-s2.0-57349111927 10.2174/157340608786242098
332. Laurora S., Tamagno E., Briatore F., Bardini P., Pizzimenti S., Toaldo C., Reffo P., Costelli P., Dianzani M. U., Danni O., Barrera G., 4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line. Free Radical Biology and Medicine 2005 38 2 215 225 2-s2.0-20844451539 10.1016/j.freeradbiomed.2004.10.014 (Pubitemid 39656132)
333. Barrera G., Martinotti S., Fazio V., Manzari V., Paradisi L., Parola M., Frati L., Dianzani M. U., Effect of 4-hydroxynonenal on c-myc expression. Toxicologic Pathology 1987 15 2 238 240 2-s2.0-0023065936
334. Barrera G., Muraca R., Pizzimenti S., Serra A., Rosso C., Saglio G., Farce M. G., Fazio V. M., Danzani M. U., Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line. Biochemical and Biophysical Research Communications 1994 203 1 553 561 2-s2.0-0028167693 10.1006/bbrc.1994.2218
335. Rinaldi M., Barrera G., Spinsanti P., Pizzimenti S., Ciafrè S. A., Parella P., Farace M. G., Signori E., Dianzani M. U., Fazio V. M., Growth inhibition and differentiation induction in murine erythroleukemia cells by 4-hydroxynonenal. Free Radical Research 2001 34 6 629 637 2-s2.0-0034928143 (Pubitemid 32694651)
336. Barrera G., Pizzimenti S., Dianzani M. U., 4-Hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway. Free Radical Biology and Medicine 2004 37 5 597 606 2-s2.0-3343002135 10.1016/j.freeradbiomed.2004. 05.023 (Pubitemid 38993508)
337. Barrera G., Pizzimenti S., Muraca R., Barbiero G., Bonelli G., Baccino F. M., Fazio V. M., Dianzani M. U., Effect of 4-hydroxynonenal on cell cycle progression and expression of differentiation-associated antigens in HL-60 cells. Free Radical Biology and Medicine 1996 20 3 455 462 2-s2.0-0029871935 10.1016/0891-5849(95)02049-7 (Pubitemid 26077869)
338. Chaudhary P., Sharma R., Sahu M., Vishwanatha J. K., Awasthi S., Awasthi Y. C., 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway. Journal of Biological Chemistry 2013 288 28 20532 20546
339. Wang X., Yang Y., Moore D. R., Nimmo S. L., Lightfoot S. A., Huycke M. M., 4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by enterococcus faecalis-infected macrophages. Gastroenterology 2012 142 3 543 551 2-s2.0-84857631398 10.1053/j.gastro.2011.11.020
340. Pettazzoni P., Pizzimenti S., Toaldo C., Sotomayor P., Tagliavacca L., Liu S., Wang D., Minelli R., Ellis L., Atadja P., Ciamporcero E., Dianzani M. U., Barrera G., Pili R., Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. Free Radical Biology and Medicine 2011 50 2 313 322 2-s2.0-78651244903 10.1016/j.freeradbiomed.2010.11.011
341. Peng Z. F., Koh C. H. V., Li Q. T., Manikandan J., Melendez A. J., Tang S. Y., Halliwell B., Cheung N. S., Deciphering the mechanism of HNE-induced apoptosis in cultured murine cortical neurons: transcriptional responses and cellular pathways. Neuropharmacology 2007 53 5 687 698 2-s2.0-34848876430 10.1016/j.neuropharm.2007.07.016 (Pubitemid 47513174)
342. Lee T.-J., Lee J.-T., Moon S.-K., Kim C.-H., Park J.-W., Kwon T. K., Age-related differential growth rate and response to 4-hydroxynonenal in mouse aortic smooth muscle cells. International Journal of Molecular Medicine 2006 17 1 29 35 2-s2.0-33644878774
343. Kakishita H., Hattori Y., Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. Life Sciences 2001 69 6 689 697 2-s2.0-0035967824 10.1016/S0024-3205(01)01166-3 (Pubitemid 32673627)
344. Tammali R., Saxena A., Srivastava S. K., Ramana K. V., Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle. Endocrinology 2010 151 5 2140 2150 2-s2.0-77953169082 10.1210/en.2010-0160
345. Huang C.-D., Chen H.-H., Wang C.-H., Chou C.-L., Lin S.-M., Lin H.-C., Kuo H.-P., Human neutrophil-derived elastase induces airway smooth muscle cell proliferation. Life Sciences 2004 74 20 2479 2492 2-s2.0-1542328799 10.1016/j.lfs.2003.07.059 (Pubitemid 38317113)
346. Pizzimenti S., Toaldo C., Pettazzoni P., Dianzani M. U., Barrera G., The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer. Cancers 2010 2 2 338 363 2-s2.0-79952275493 10.3390/cancers2020338
347. Trachootham D., Alexandre J., Huang P., Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery 2009 8 7 579 591 2-s2.0-67650071137 10.1038/nrd2803
348. Pelicano H., Carney D., Huang P., ROS stress in cancer cells and therapeutic implications. Drug Resistance Updates 2004 7 2 97 110 2-s2.0-2942593991 10.1016/j.drup.2004.01.004 (Pubitemid 38736063)
349. Hileman E. O., Liu J., Albitar M., Keating M. J., Huang P., Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemotherapy and Pharmacology 2004 53 3 209 219 2-s2.0-1442360000 10.1007/s00280-003-0726-5 (Pubitemid 38293718)
350. Chaudhary P., Sharma R., Sharma A., Vatsyayan R., Yadav S., Singhal S. S., Rauniyar N., Prokai L., Awasthi S., Awasthi Y. C., Mechanisms of 4-hydroxy-2-nonenal induced pro- and anti-apoptotic signaling. Biochemistry 2010 49 29 6263 6275 2-s2.0-77954824524 10.1021/bi100517x
351. Locksley R. M., Killeen N., Lenardo M. J., The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001 104 4 487 501 2-s2.0-0035936797 10.1016/S0092-8674(01)00237-9 (Pubitemid 32201945)
352. Elmore S., Apoptosis: a review of programmed cell death. Toxicologic Pathology 2007 35 4 495 516 (Pubitemid 46911891)
353. Franklin J. L., Redox regulation of the intrinsic pathway in neuronal apoptosis. Antioxidants and Redox Signaling 2011 14 8 1437 1448 2-s2.0-79952825980 10.1089/ars.2010.3596
354. Haupt S., Berger M., Goldberg Z., Haupt Y., Apoptosis-the p53 network. Journal of Cell Science 2003 116 20 4077 4085 2-s2.0-0242319666 10.1242/jcs.00739 (Pubitemid 37337082)
355. Abarikwu S. O., Pant A. B., Farombi E. O., 4-hydroxynonenal induces mitochondrial-mediated apoptosis and oxidative stress in SH-SY5Y human neuronal cells. Basic and Clinical Pharmacology and Toxicology 2012 110 5 441 448 2-s2.0-84859855659 10.1111/j.1742-7843.2011.00834.x
356. Sharma A., Sharma R., Chaudhary P., Vatsyayan R., Pearce V., Jeyabal P. V. S., Zimniak P., Awasthi S., Awasthi Y. C., 4-hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells. Archives of Biochemistry and Biophysics 2008 480 2 85 94 2-s2.0-55849108107 10.1016/j.abb.2008.09.016
357. Sharma R., Sharma A., Dwivedi S., Zimniak P., Awasthi S., Awasthi Y. C., 4-hydroxynonenal self-limits Fas-mediated DISC-independent apoptosis by promoting export of Daxx from the nucleus to the cytosol and its binding to Fas. Biochemistry 2008 47 1 143 156 2-s2.0-37848999061 10.1021/bi701559f
358. Vaillancourt F., Fahmi H., Shi Q., Lavigne P., Ranger P., Fernandes J. C., Benderdour M., 4-hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase. Arthritis Research and Therapy 2008 10 5, article R107 2-s2.0-54749095969 10.1186/ar2503
359. Awasthi Y. C., Sharma R., Sharma A., Yadav S., Singhal S. S., Chaudhary P., Awasthi S., Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. Free Radical Biology and Medicine 2008 45 2 111 118 2-s2.0-44649173705 10.1016/j.freeradbiomed.2008.04.007
360. Doorn J. A., Petersen D. R., Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chemical Research in Toxicology 2002 15 11 1445 1450 2-s2.0-0036852609 10.1021/tx025590o (Pubitemid 35364906)
361. Sayre L. M., Lin D., Yuan Q., Zhu X., Tang X., Protein adducts generated from products of lipid oxidation: focus on HNE and ONE. Drug Metabolism Reviews 2006 38 4 651 675 2-s2.0-33845390864 10.1080/03602530600959508 (Pubitemid 44903261)
362. Monroy C. A., Doorn J. A., Roman D. L., Modification and functional inhibition of regulator of G-protein signaling 4 (RGS4) by 4-Hydroxy-2-nonenal. Chemical Research in Toxicology 2013 26 12 1832 1839
363. Poli G., Schaur R. J., Siems W. G., Leonarduzzi G., 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Medicinal Research Reviews 2008 28 4 569 631 2-s2.0-45249124663 10.1002/med.20117 (Pubitemid 351842143)
364. 2-propanodeoxyguanine DNA adducts by human cell nuclear extracts. Biochemistry 2004 43 23 7514 7521 2-s2.0-2942593925 10.1021/bi049877r (Pubitemid 38745767)
365. Choudhury S., Dyba M., Pan J., Roy R., Chung F. L., Repair kinetics of acrolein- and (E)-4-hydroxy-2-nonenal-derived DNA adducts in human colon cell extracts. Mutation Research 2013 751-752 15 23
366. Gros L., Ishchenko A. A., Saparbaev M., Enzymology of repair of etheno-adducts. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis 2003 531 1-2 219 229 2-s2.0-0344154306 10.1016/j.mrfmmm.2003.07.008 (Pubitemid 37456734)
367. Nair J., Srivatanakul P., Haas C., Jedpiyawongse A., Khuhaprema T., Seitz H. K., Bartsch H., High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutation Research: Fundamental and Molecular Mechanisms of Mutagenesis 2010 683 1-2 23 28 2-s2.0-71549121960 10.1016/j.mrfmmm.2009.10.002
368. Nair J., Gansauge F., Beger H., Dolara P., Winde G., Bartsch H., Increased etheno-DNA adducts in affected tissues of patients suffering from Crohn's disease, ulcerative colitis, and chronic pancreatitis. Antioxidants and Redox Signaling 2006 8 5-6 1003 1010 2-s2.0-33745847542 10.1089/ars.2006.8.1003 (Pubitemid 44036517)
369. Richard S., Lewis J., Hazardous Chemicals Desk Reference 2008 John Wiley & Sons
370. Ayala A., Parrado J., Bougria M., Machado A., Effect of oxidative stress, produced by cumene hydroperoxide, on the various steps of protein synthesis. Modifications of elongation factor-2. Journal of Biological Chemistry 1996 271 38 23105 23110 2-s2.0-0029841946 10.1074/jbc.271.38.23105 (Pubitemid 26314744)
371. Parrado J., Bougria M., Ayala A., Castaño A., Machado A., Effects of aging on the various steps of protein synthesis: fragmentation of elongation factor 2. Free Radical Biology and Medicine 1999 26 3-4 362 370 2-s2.0-0032901078 10.1016/S0891-5849(98)00202-0 (Pubitemid 29013468)
372. Parrado J., Bougria M., Ayala A., MacHado A., Induced mono-(ADP)-ribosylation of rat liver cytosolic proteins by lipid peroxidant agents. Free Radical Biology and Medicine 1999 26 9-10 1079 1084 2-s2.0-0033028705 10.1016/S0891-5849(98)00316-5 (Pubitemid 29262691)
373. Parrado J., Absi E. H., Machado A., Ayala A., 'In vitro' effect of cumene hydroperoxide on hepatic elongation factor-2 and its protection by melatonin. Biochimica et Biophysica Acta: General Subjects 2003 1624 1-3 139 144 2-s2.0-0344827189 10.1016/j.bbagen.2003.10.006 (Pubitemid 37464951)
374. Argüelles S., Machado A., Ayala A., 'In vitro' effect of lipid peroxidation metabolites on elongation factor-2. Biochimica et Biophysica Acta: General Subjects 2006 1760 3 445 452 2-s2.0-33644903770 10.1016/j.bbagen.2005. 12.019
375. Arguelles S., Cano M., Machado A., Ayala A., Effect of aging and oxidative stress on elongation factor-2 in hypothalamus and hypophysis. Mechanisms of Ageing and Development 2011 132 1-2 55 64 2-s2.0-79251595904 10.1016/j.mad.2010.12.002
376. Argüelles S., Muñoz M. F., Cano M., Machado A., Ayala A., In vitro and in vivo protection by melatonin against the decline of elongation factor-2 caused by lipid peroxidation: preservation of protein synthesis. Journal of Pineal Research 2012 53 1 1 10
377. Argüelles S., Machado A., Ayala A., 'In vitro' protective effect of a hydrophilic vitamin E analogue on the decrease in levels of elongation factor 2 in conditions of oxidative stress. Gerontology 2007 53 5 282 288 2-s2.0-34548062369 10.1159/000102948 (Pubitemid 47294452)
378. Arguelles S., Cano M., Machado A., Ayala A., Comparative study of the In Vitro protective effects of several antioxidants on elongation factor 2 under oxidative stress conditions. Bioscience, Biotechnology and Biochemistry 2010 74 7 1373 1379 2-s2.0-77955194558 10.1271/bbb.100054
379. Argüelles S., Camandola S., Hutchison E. R., Cutler R. G., Ayala A., Mattson M. P., Molecular control of the amount, subcellular location, and activity state of translation elongation factor 2 in neurons experiencing stress. Free Radical Biology and Medicine 2013 61 61 71
380. Argüelles S., Camandola S., Cutler R. G., Ayala A., Mattson M. P., Elongation factor 2 diphthamide is critical for translation of two IRES-dependent protein targets, XIAP and FGF2, under oxidative stress conditions. Free Radical Biology and Medicine 2013 67 131 138
381. Aboua Y. G., Brooks N., Mahfouz R. Z., Agarwal A., du Plessis S. S., A red palm oil diet can reduce the effects of oxidative stress on rat spermatozoa. Andrologia 2012 44 supplement 1 32 40
382. Kumar T. R., Muralidhara M., Induction of oxidative stress by organic hydroperoxides in testis and epididymal sperm of rats in vivo. Journal of Andrology 2007 28 1 77 85 2-s2.0-33846018570 10.2164/jandrol.106.000265 (Pubitemid 46048081)
383. Chan T. S., Shangari N., Wilson J. X., Chan H., Butterworth R. F., O'Brien P. J., The biosynthesis of ascorbate protects isolated rat hepatocytes from cumene hydroperoxide-mediated oxidative stress. Free Radical Biology and Medicine 2005 38 7 867 873 2-s2.0-14644439227 10.1016/j.freeradbiomed.2004.12. 006 (Pubitemid 40321078)
384. Shvedova A. A., Kisin E. R., Murray A. R., Kommineni C., Castranova V., Mason R. P., Kadiiska M. B., Gunther M. R., Antioxidant balance and free radical generation in vitamin E-deficient mice after dermal exposure to cumene hydroperoxide. Chemical Research in Toxicology 2002 15 11 1451 1459 2-s2.0-0036851874 10.1021/tx0200313 (Pubitemid 35364907)
385. Alam A., Iqbal M., Saleem M., Ahmed S.-U., Sultana S., Myrica nagi attenuates cumene hydroperoxide-induced cutaneous oxidative stress and toxicity in Swiss albino mice. Pharmacology and Toxicology 2000 86 5 209 214 2-s2.0-0034072323 (Pubitemid 30333647)
386. Jamal M., Masood A., Belcastro R., Lopez L., Li J., Belik J., Jankov R. P., Keith Tanswell A., Lipid hydroperoxide formation regulates postnatal rat lung cell apoptosis and alveologenesis. Free Radical Biology and Medicine 2013 55 83 92
387. Hong C. O., Rhee C. H., Won N. H., Choi H. D., Lee K. W., Protective effect of 70% ethanolic extract of Lindera obtusiloba Blume on tert-butyl hydroperoxide-induced oxidative hepatotoxicity in rats. Food and Chemical Toxicology 2013 53 214 220
388. Oh J. M., Jung Y. S., Jeon B. S., Yoon B. I., Lee K. S., Kim B. H., Oh S. J., Kim S. K., Evaluation of hepatotoxicity and oxidative stress in rats treated with tert-butyl hydroperoxide. Food and Chemical Toxicology 2012 50 5 1215 1221
389. Kim M.-K., Lee H.-S., Kim E.-J., Won N.-H., Chi Y.-M., Kim B.-C., Lee K.-W., Protective effect of aqueous extract of Perilla frutescens on tert-butyl hydroperoxide-induced oxidative hepatotoxicity in rats. Food and Chemical Toxicology 2007 45 9 1738 1744 2-s2.0-34547125977 10.1016/j.fct.2007.03.009 (Pubitemid 47102511)
390. Kaur P., Kaur G., Bansal M. P., Tertiary-butyl hydroperoxide induced oxidative stress and male reproductive activity in mice: role of transcription factor NF- B and testicular antioxidant enzymes. Reproductive Toxicology 2006 22 3 479 484 2-s2.0-33748435753 10.1016/j.reprotox.2006.03.017 (Pubitemid 44344457)
391. Liu C. L., Wang J. M., Chu C. Y., Cheng M. T., Tseng T. H., In vivo protective effect of protocatechuic acid on tert-butyl hydroperoxide-induced rat hepatotoxicity. Food and Chemical Toxicology 2002 40 5 635 641
392. Hix S., Kadiiska M. B., Mason R. P., Augusto O., In vivo metabolism of tert-Butyl hydroperoxide to methyl radicals. EPR spin-trapping and DNA methylation studies. Chemical Research in Toxicology 2000 13 10 1056 1064 2-s2.0-0033789365 10.1021/tx000130l
393. Ma J. Q., Ding J., Zhang L., Liu C. M., Hepatoprotective properties of sesamin against CCl4 induced oxidative stress-mediated apoptosis in mice via JNK pathway. Food and Chemical Toxicology 2013 64 41 48
394. Yeh Y. H., Hsieh Y. L., Lee Y. T., Effects of yam peel extract against carbon tetrachloride-induced hepatotoxicity in rats. Journal of Agricultural and Food Chemistry 2013 61 30 7387 7396
395. Knockaert L., Berson A., Ribault C., Prost P.-E., Fautrel A., Pajaud J., Lepage S., Lucas-Clerc C., Bégué J.-M., Fromenty B., Robin M.-A., Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver. Laboratory Investigation 2012 92 3 396 410 2-s2.0-84857715739 10.1038/labinvest.2011.193
396. Choi J.-H., Kim D.-W., Yun N., Choi J.-S., Islam M. N., Kim Y.-S., Lee S.-M., Protective effects of hyperoside against carbon tetrachloride-induced liver damage in mice. Journal of Natural Products 2011 74 5 1055 1060 2-s2.0-79957852763 10.1021/np200001x
397. Kim H.-Y., Kim J.-K., Choi J.-H., Jung J.-Y., Oh W.-Y., Kim D. C., Lee H. S., Kim Y. S., Kang S. S., Lee S.-H., Lee S.-M., Hepatoprotective effect of pinoresinol on carbon tetrachloride-induced hepatic damage in mice. Journal of Pharmacological Sciences 2010 112 1 105 112 2-s2.0-75749084477 10.1254/jphs.09234FP
398. Wang H., Wei W., Wang N.-P., Gui S.-Y., Wu L., Sun W.-Y., Xu S.-Y., Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress. Life Sciences 2005 77 15 1902 1915 2-s2.0-23044488162 10.1016/j.lfs.2005.04.013 (Pubitemid 41058993)
399. Lugo-Huitrón R., Ugalde Muñiz P., Pineda B., Pedraza-Chaverrí J., Ríos C., Pérez-de la Cruz V.,
400. Maldonado P. D., Pérez-De La Cruz V., Torres-Ramos M., Silva-Islas C., Lecona-Vargas R., Lugo-Huitrón R., Blanco-Ayala T., Ugalde-Muñiz P., Vázquez-Cervantes G. I., Fortoul T. I., Ali S. F., Santamaría A., Selenium-induced antioxidant protection recruits modulation of thioredoxin reductase during excitotoxic/pro-oxidant events in the rat striatum. Neurochemistry International 2012 61 2 195 206
401. Sreekala S., Indira M., Impact of co administration of selenium and quinolinic acid in the rat's brain. Brain Research 2009 1281 101 107 2-s2.0-67649414190 10.1016/j.brainres.2009.05.036
402. Ryu J. K., Choi H. B., McLarnon J. G., Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum. Neurobiology of Disease 2005 20 2 550 561 2-s2.0-26944485506 10.1016/j.nbd.2005.04.010 (Pubitemid 41476281)
403. Rossato J. I., Zeni G., Mello C. F., Rubin M. A., Rocha J. B. T., Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neuroscience Letters 2002 318 3 137 140 2-s2.0-0036468684 10.1016/S0304-3940(01)02504-6 (Pubitemid 34136028)
404. Santamaría A., Jiménez-Capdeville M. E., Camacho A., Rodríguez-Martínez E., Flores A., Galván-Arzate S., In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. NeuroReport 2001 12 12 2693 2696 (Pubitemid 32803201)
405. Rodríguez-Martínez E., Camacho A., Maldonado P. D., Pedraza-Chaverrí J., Santamaría D., Galván-Arzate S., Santamaría A., Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Research 2000 858 2 436 439 (Pubitemid 30120008)
406. Jomova K., Valko M., Advances in metal-induced oxidative stress and human disease. Toxicology 2011 283 2-3 65 87 2-s2.0-79954642381 10.1016/j.tox.2011. 03.001
407. Boveris A., Musacco-Sebio R., Ferrarotti N., Saporito- Magriñá C., Torti H., Massot F., Repetto M. G., The acute toxicity of iron and copper: biomolecule oxidation and oxidative damage in rat liver. Journal of Inorganic Biochemistry 2012 116 63 69
408. Özcelik D., Uzun H., Naziroglu M., N-acetylcysteine attenuates copper overload-induced oxidative injury in brain of rat. Biological Trace Element Research 2012 147 1-3 292 298 2-s2.0-84855581202 10.1007/s12011-012- 9320-1
409. Alexandrova A., Petrov L., Georgieva A., Kessiova M., Tzvetanova E., Kirkova M., Kukan M., Effect of copper intoxication on rat liver proteasome activity: relationship with oxidative stress. Journal of Biochemical and Molecular Toxicology 2008 22 5 354 362 2-s2.0-55049095513 10.1002/jbt.20248
410. Scharf B., Trombetta L. D., The effects of the wood preservative copper dimethyldithiocarbamate in the hippocampus of maternal and newborn Long-Evans rats. Toxicology Letters 2007 174 1-3 117 124 2-s2.0-35348978352 10.1016/j.toxlet.2007.08.017 (Pubitemid 47599864)
411. Parveen K., Khan M. R., Siddiqui W. A., Pycnogenol prevents potassium dichromate (K2Cr2O7)-induced oxidative damage and nephrotoxicity in rats. Chemico-Biological Interactions 2009 181 3 343 350 2-s2.0-70249112934 10.1016/j.cbi.2009.08.001
412. Kotyzova D., Hodková A., Bludovská M., Eybl V., Effect of chromium (VI) exposure on antioxidant defense status and trace element homeostasis in acute experiment in rat. Toxicology and Industrial Health. In press
413. Karaca S., Eraslan G., The effects of flaxseed oil on cadmium-induced oxidative stress in rats. Biological Trace Element Research 2013 155 3 423 430
414. Chen Q., Zhang R., Li W., Niu Y., Guo H., Liu X., Hou Y., Zhao L., The protective effect of grape seed procyanidin extract against cadmium-induced renal oxidative damage in mice. Environmental Toxicology and Pharmacology 2013 36 3 759 768
415. Leelavinothan P., Kalist S., Beneficial effect of hesperetin on cadmium induced oxidative stress in rats: an in vivo and in vitro study. European Review for Medical and Pharmacological Sciences 2011 15 9 992 1002 2-s2.0-80054851875
416. Ognjanović B. I., Marković S. D., Ethordević N. Z., Trbojević I. S., Stajn A. S., Saicić Z. S., Cadmium-induced lipid peroxidation and changes in antioxidant defense system in the rat testes: protective role of coenzyme Q(10) and vitamin E. Reproductive Toxicology 2010 29 2 191 197
417. Amudha K., Pari L., Beneficial role of naringin, a flavanoid on nickel induced nephrotoxicity in rats. Chemico-Biological Interactions 2011 193 1 57 64 2-s2.0-79959955771 10.1016/j.cbi.2011.05.003
418. Pari L., Amudha K., Hepatoprotective role of naringin on nickel-induced toxicity in male Wistar rats. European Journal of Pharmacology 2011 650 1 364 370 2-s2.0-78649737499 10.1016/j.ejphar.2010.09.068
419. Scibior A., Gołȩbiowska D., Niedźwiecka I., Magnesium can protect against vanadium-induced lipid peroxidation in the hepatic tissue. Oxidative Medicine and Cellular Longevity 2013 2013 11 802734 10.1155/2013/802734
420. Ścibior A., Zaporowska H., Niedźwiecka I., Lipid peroxidation in the kidney of rats treated with V and/or Mg in drinking water. Journal of Applied Toxicology 2010 30 5 487 496 2-s2.0-77955359527 10.1002/jat.1520
421. Ścibior A., Zaporowska H., Ostrowski J., Banach A., Combined effect of vanadium(V) and chromium(III) on lipid peroxidation in liver and kidney of rats. Chemico-Biological Interactions 2006 159 3 213 222 2-s2.0-30944434392 10.1016/j.cbi.2005.11.008 (Pubitemid 43112432)
422. Martins E. N., Pessano N. T. C., Leal L., Roos D. H., Folmer V., Puntel G. O., Rocha J. B. T., Aschner M., Ávila D. S., Puntel R. L., Protective effect of Melissa officinalis aqueous extract against Mn-induced oxidative stress in chronically exposed mice. Brain Research Bulletin 2012 87 1 74 79 2-s2.0-84155163943 10.1016/j.brainresbull.2011.10.003
423. Chtourou Y., Fetoui H., Sefi M., Trabelsi K., Barkallah M., Boudawara T., Kallel H., Zeghal N., Silymarin, a natural antioxidant, protects cerebral cortex against manganese-induced neurotoxicity in adult rats. BioMetals 2010 23 6 985 996 2-s2.0-78349312428 10.1007/s10534-010-9345-x
424. Chen M. T., Cheng G. W., Lin C. C., Chen B. H., Huang Y. L., Effects of acute manganese chloride exposure on lipid peroxidation and alteration of trace metals in rat brain. Biological Trace Element Research 2006 110 2 163 178
425. Salama S. A., Omar H. A., Maghrabi I. A., Alsaeed M. S., El-Tarras A. E., Iron supplementation at high altitudes induces inflammation and oxidative injury to lung tissues in rats. Toxicology and Applied Pharmacology 2014 274 1 1 6
426. Kim J., Paik H. D., Yoon Y. C., Park E., Whey protein inhibits iron overload-induced oxidative stress in rats. Journal of Nutritional Science and Vitaminology 2013 59 3 198 205
427. Arruda L. F., Arruda S. F., Campos N. A., de Valencia F. F., de Siqueira E. M., Dietary iron concentration may influence aging process by altering oxidative stress in tissues of adult rats. PloS ONE 2013 8 4 e61058
428. Yu H. C., Feng S. F., Chao P. L., Lin A. M. Y., Anti-inflammatory effects of pioglitazone on iron-induced oxidative injury in the nigrostriatal dopaminergic system. Neuropathology and Applied Neurobiology 2010 36 7 612 622 2-s2.0-78349268336 10.1111/j.1365-2990.2010.01107.x
429. Oktar S., Yönden Z., Aydin M., Ilhan S., Alçin E., Oztürk O. H., Protective effects of caffeic acid phenethyl ester on iron-induced liver damage in rats. Journal of Physiology and Biochemistry 2009 65 4 339 344
430. Kokoszko A., Dabrowski J., Lewiński A., Karbownik-Lewińska M., Protective effects of GH and IGF-I against iron-induced lipid peroxidation in vivo. Experimental and Toxicologic Pathology 2008 60 6 453 458
431. Maharaj D. S., Maharaj H., Daya S., Glass B. D., Melatonin and 6-hydroxymelatonin protect against iron-induced neurotoxicity. Journal of Neurochemistry 2006 96 1 78 81 2-s2.0-33644839704 10.1111/j.1471-4159.2005. 03532.x
432. Morales N. P., Yamaguchi Y., Murakami K., Kosem N., Utsumi H., Hepatic reduction of carbamoyl-PROXYL in ferric nitrilotriacetate induced iron overloaded mice: an in vivo ESR study. Biological and Pharmaceutical Bulletin 2012 35 7 1035 1040
433. Völkel W., Alvarez-Sánchez R., Weick I., Mally A., Dekant W., Pähler A., Glutathione conjugates of 4-hydroxy-2(E)-nonenal as biomarkers of hepatic oxidative stress-induced lipid peroxidation in rats. Free Radical Biology and Medicine 2005 38 11 1526 1536 2-s2.0-18844408406 10.1016/j.freeradbiomed.2005.02.015 (Pubitemid 40693837)
434. Eybl V., Kotyzová D., Černá P., Koutenský J., Effect of melatonin, curcumin, quercetin, and resveratrol on acute ferric nitrilotriacetate (Fe-NTA)-induced renal oxidative damage in rat. Human and Experimental Toxicology 2008 27 4 347 353 2-s2.0-52649104870 10.1177/0960327108094508